韓靚嫻的个人主页 - 老虎社区

韓靚嫻

韓靚嫻

暂无个人介绍

IP属地：未知

9关注

2粉丝

0主题

0勋章

2021-10-03

💰💰💰

3 Stocks That Can Double Again in the Fourth Quarter

2021-09-29

Appreciate the insight. I have added some of them to my watchlist. I think it’s really helpful for people like me who has small capital. 🍻

Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter

2021-09-25

I’m in my twenties, just started my career a year ago, started to learn about trading with small capital. Sometimes I wonder if it’s wise to trade such “expensive” stock? AMZN priced at close to $3.5k or 1 unit. $3.5k equivalent to approximately 4 units of TSLA.

2 Expensive Stocks That Can Still Produce Great Returns in the Long Run

2021-09-20

Malaysia pandemic 🏳️

抱歉，原内容已删除

2021-09-20

Appreciate the insight 🙏🏻Thank you

Toplines Before US Market Open on Monday

2021-09-19

👍🏻

Why Palantir Shares Are Trading Higher Today

2021-09-19

Cheers towards financial freedom 💰

7 ways men live without working in America

2021-09-18

Awesome!

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4090310005874460","uuid":"4090310005874460","gmtCreate":1627207859543,"gmtModify":1631950851227,"name":"韓靚嫻","pinyin":"韓靚嫻韓靚嫻","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":9,"tweetSize":8,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.05.25","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.27","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":867178738,"gmtCreate":1633231618615,"gmtModify":1633231618736,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"💰💰💰","listText":"💰💰💰","text":"💰💰💰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867178738","repostId":"1134305481","repostType":4,"repost":{"id":"1134305481","pubTimestamp":1633152909,"share":"https://www.laohu8.com/m/news/1134305481?lang=&edition=full","pubTime":"2021-10-02 13:35","market":"hk","language":"en","title":"3 Stocks That Can Double Again in the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=1134305481","media":"The motley fool","summary":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this mo","content":"<p>Key Points</p>\n<ul>\n <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>\n <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>\n <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li>\n</ul>\n<p></p>\n<p>It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p>\n<p><b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p>\n<p>1. Crocs</p>\n<p>Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p>\n<p>The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p>\n<p>The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p>\n<p>Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p>\n<p>2. AMC Entertainment</p>\n<p>You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p>\n<p>However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p>\n<p>Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p>\n<p>3. Upstart</p>\n<p>I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p>\n<p>Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p>\n<p>With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Can Double Again in the Fourth Quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Can Double Again in the Fourth Quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-02 13:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","AMC":"AMC院线","CROX":"卡骆驰"},"source_url":"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134305481","content_text":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.\nUpstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.\n\n\nIt's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?\nCrocs (NASDAQ:CROX),AMC Entertainment(NYSE:AMC), andUpstart (NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.\n1. Crocs\nRemember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.\nThe comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.\nThe year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?\nDespite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.\n2. AMC Entertainment\nYou may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.\nHowever, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?\nFundamentally speaking, the catalysts are also there.Shang-Chi and the Legend of the Ten Ringsshattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.\n3. Upstart\nI love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.\nGrowth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.\nWith Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862879045,"gmtCreate":1632872589466,"gmtModify":1632872589466,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Appreciate the insight. I have&nbsp;added some of them to my&nbsp;watchlist. I think it’s really helpful for people like me who has small capital. 🍻","listText":"Appreciate the insight. I have&nbsp;added some of them to my&nbsp;watchlist. I think it’s really helpful for people like me who has small capital. 🍻","text":"Appreciate the insight. I have added some of them to my watchlist. I think it’s really helpful for people like me who has small capital. 🍻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862879045","repostId":"2170672462","repostType":4,"repost":{"id":"2170672462","pubTimestamp":1632835246,"share":"https://www.laohu8.com/m/news/2170672462?lang=&edition=full","pubTime":"2021-09-28 21:20","market":"us","language":"en","title":"Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2170672462","media":"Motley Fool","summary":"Bargains can still be found, even with the broader market near an all-time high.","content":"<p>If investors thought the coronavirus crash was historic, the bounce-back rally from the March 2020 bottom has been even more impressive. The benchmark <b>S&amp;P 500</b> took less than 17 months to double from its lows, and it's now gone 10 months without so much as a 5% downside correction. Patience is truly paying off for long-term investors.</p>\n<p>But just because the broader market is a stone's throw from a record high doesn't mean investors can't still find bargains. If you've got $1,000 ready to invest, which won't be needed for bill or emergencies, the following five stocks would make for perfect buys for the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8cf8fd6cbc9120f885acecdfb00d5835\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Novavax</h2>\n<p>While I'm generally not a fan of chasing the coronavirus stocks after they've catapulted into the stratosphere, clinical-stage biotech stock <b>Novavax</b> (NASDAQ:NVAX) is the rare exception. It's unlikely to remain a clinical-stage company for much longer and could offer clear advantages that'll help it become a top vaccine player.</p>\n<p>The company's coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373, led to an 89.7% vaccine efficacy (VE) in a large-scale trial in the U.K. earlier this year, and it produced a nearly identical 90.4% VE in a large-scale trial in the U.S. and Mexico in June. This initial efficacy, coupled with the less-than-stellar uptake from <b>AstraZeneca</b>'s and <b>Johnson &amp; Johnson</b>'s COVID-19 vaccines, should open the door for Novavax to become the No. 3 player in developed markets.</p>\n<p>Also working in Novavax's favor is the mutability of the SARS-CoV-2 virus that causes COVID-19. Novavax's drug-development platform is capable of quickly bringing variant-specific vaccines to trial, if necessary. The company could also benefit from the need for booster shots, depending on how long vaccine-based immunity lasts.</p>\n<p>Novavax has an opportunity to beat its peers to market with a combination COVID-19/influenza vaccine, as well. This could be a differentiating vaccine that really allows the company to stand out.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/31d9e4dd60375f8f383f0c222a7633a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Exelixis</h2>\n<p>Biotech stocks are a common theme on this list of perfect stocks to buy for the fourth quarter. Cancer drug developer <b>Exelixis</b> (NASDAQ:EXEL) offers the right blend of growth and value to make patient investors richer.</p>\n<p>The superstar for Exelixis continues to be cancer drug Cabometyx, which derives the bulk of its sales from its first-and-second-line approvals in renal cell carcinoma (RCC) and its approval to treat advanced hepatocellular carcinoma. These indications should help Cabometyx top $1 billion in recurring sales either this year or 2022.</p>\n<p>The only reason this company is as inexpensive as it is now -- 21 times forward-year earnings for sustainable mid-teens sales growth -- is the disappointing update from the Cosmic-312 trial. Though the combination of Cabometyx and atezolizumab led to a statistically significant improvement in progression-free survival for previously untreated liver cancer patients, Exelixis notes that it's unlikely to demonstrate a statistically significant improvement in overall survival by trial completion in early 2022.</p>\n<p>While this might sound like a disappointment, it isn't. It's par for the course when developing blockbuster cancer drugs. Cabometyx failed in a late-stage study targeted at prostate cancer patients in 2014 but has since bounced back to gain numerous approvals. With this key drug being examined in close to six dozen clinical trials, label expansion opportunities remain abundant for Exelixis.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e5596b9cd58d43ee65824bd7892b9c5e\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Broadcom</h2>\n<p>Stepping outside the healthcare arena for the moment, semiconductor solutions provider <b>Broadcom</b> (NASDAQ:AVGO) is a perfect stock to put $1,000 to work in for the fourth quarter. I say \"perfect,\" because Broadcom is at the center of two very sustainable growth trends.</p>\n<p>First, it's going to be a multiyear beneficiary of the rollout of 5G wireless infrastructure. A majority of Broadcom's revenue comes from wireless chips and other accessories found in smartphones. Because it's been a decade since consumers and businesses have benefited from an upgrade to wireless download speeds, the expectation is that we'll see a sustainable, multiyear device replacement cycle. This should allow Broadcom to lock in its orders months or years in advance.</p>\n<p>But it's not just smartphones that should have investors excited about Broadcom. The pandemic has also accelerated the shift of enterprise and consumer data into the cloud. This means data center demand should be strong for a long time to come. Broadcom is a provider of connectivity and access chips used by enterprise data centers.</p>\n<p>The icing on the cake here is that the company has grown its quarterly dividend by more than 5,000% in less than 11 years. Investors can collect a nearly 3% yield as they sit back and watch Broadcom's profitability climb.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2fc0013108c05865a77a8fa2e9b54b23\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Vertex Pharmaceuticals</h2>\n<p>Similar to Exelixis, specialty biotech stock <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) offers the right blend of double-digit sales growth and insane value (a forward-year price-to-earnings ratio of only 14), which makes it a no-brainer buy for the fourth quarter.</p>\n<p>What allows Vertex to stand out is its overwhelming success in developing multiple generations of treatments for patients with cystic fibrosis (CF). CF is a genetic disease characterized by thick mucus production that can obstruct the pancreas and/or lungs. Vertex's latest treatment, combination therapy Trikafta, was approved five months ahead of the U.S. Food and Drug Administration's review date, and is pacing $5 billion in annual run-rate sales despite hitting pharmacy shelves less than two years ago.</p>\n<p>Keeping with the similarities to Exelixis, Vertex was hit hard twice over the past year after two separate experimental treatments targeting alpha-1 antitrypsin deficiency were discontinued in mid-stage trials. Nevertheless, Vertex has more than a half-dozen combined internal and out-licensed treatments in development for a variety of indications. Even though its CF franchise is well-protected from competition, the company is working on an expansive pipeline of products.</p>\n<p>And don't overlook Vertex's cash pile. It ended June with about $6.7 billion in cash and cash equivalents, which is more than enough to fuel internal development, fund novel partnerships, or make acquisitions.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39a1727edeb0317fbc6386d8981fd8e0\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Teladoc Health</h2>\n<p>Lastly, buying shares of telemedicine kingpin <b>Teladoc Health</b> (NYSE:TDOC) would be a perfect use of $1,000 for the fourth quarter.</p>\n<p>When the pandemic hit, there's no sugarcoating that Teladoc was in the right place at the right time. With doctors wanting to keep potentially sick and high-risk people out of their offices, they regularly turned to virtual visit platforms, such as those offered by Teladoc. Last year, Teladoc handled almost 10.6 million visits, which was well over double the 4.14 million visits in 2019.</p>\n<p>Some skeptics have cautioned that Teladoc could be a one-hit wonder considering the worst of the pandemic may now be in the rearview mirror. However, this view overlooks the many lasting changes telemedicine brings to the table. It's far more convenient for patients, can allow doctors to keep better tabs on their chronic-care patients, and should result in better patient outcomes and lower total treatment costs for insurers. There's a reason Teladoc's annual sales growth averaged 74% in the six years leading up to the pandemic.</p>\n<p>Teladoc Health also acquired the nation's leading applied health signals company, Livongo Health, in the fourth quarter of 2020. Livongo leans on artificial intelligence to send tips to its chronic-care members to help them lead healthier lives. While most of Livongo' 715,000 chronic-care enrollees are diabetics, it aims to offer its services to those with weight management issues and hypertension, as well. In other words, we're watching the very early innings of a personalized care disruptor.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-28 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/28/got-1000-5-perfect-stocks-buy-for-fourth-quarter/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If investors thought the coronavirus crash was historic, the bounce-back rally from the March 2020 bottom has been even more impressive. The benchmark S&P 500 took less than 17 months to double from ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/28/got-1000-5-perfect-stocks-buy-for-fourth-quarter/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","EXEL":"伊克力西斯","VRTX":"福泰制药","AVGO":"博通","TDOC":"Teladoc Health Inc."},"source_url":"https://www.fool.com/investing/2021/09/28/got-1000-5-perfect-stocks-buy-for-fourth-quarter/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170672462","content_text":"If investors thought the coronavirus crash was historic, the bounce-back rally from the March 2020 bottom has been even more impressive. The benchmark S&P 500 took less than 17 months to double from its lows, and it's now gone 10 months without so much as a 5% downside correction. Patience is truly paying off for long-term investors.\nBut just because the broader market is a stone's throw from a record high doesn't mean investors can't still find bargains. If you've got $1,000 ready to invest, which won't be needed for bill or emergencies, the following five stocks would make for perfect buys for the fourth quarter.\nImage source: Getty Images.\nNovavax\nWhile I'm generally not a fan of chasing the coronavirus stocks after they've catapulted into the stratosphere, clinical-stage biotech stock Novavax (NASDAQ:NVAX) is the rare exception. It's unlikely to remain a clinical-stage company for much longer and could offer clear advantages that'll help it become a top vaccine player.\nThe company's coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373, led to an 89.7% vaccine efficacy (VE) in a large-scale trial in the U.K. earlier this year, and it produced a nearly identical 90.4% VE in a large-scale trial in the U.S. and Mexico in June. This initial efficacy, coupled with the less-than-stellar uptake from AstraZeneca's and Johnson & Johnson's COVID-19 vaccines, should open the door for Novavax to become the No. 3 player in developed markets.\nAlso working in Novavax's favor is the mutability of the SARS-CoV-2 virus that causes COVID-19. Novavax's drug-development platform is capable of quickly bringing variant-specific vaccines to trial, if necessary. The company could also benefit from the need for booster shots, depending on how long vaccine-based immunity lasts.\nNovavax has an opportunity to beat its peers to market with a combination COVID-19/influenza vaccine, as well. This could be a differentiating vaccine that really allows the company to stand out.\nImage source: Getty Images.\nExelixis\nBiotech stocks are a common theme on this list of perfect stocks to buy for the fourth quarter. Cancer drug developer Exelixis (NASDAQ:EXEL) offers the right blend of growth and value to make patient investors richer.\nThe superstar for Exelixis continues to be cancer drug Cabometyx, which derives the bulk of its sales from its first-and-second-line approvals in renal cell carcinoma (RCC) and its approval to treat advanced hepatocellular carcinoma. These indications should help Cabometyx top $1 billion in recurring sales either this year or 2022.\nThe only reason this company is as inexpensive as it is now -- 21 times forward-year earnings for sustainable mid-teens sales growth -- is the disappointing update from the Cosmic-312 trial. Though the combination of Cabometyx and atezolizumab led to a statistically significant improvement in progression-free survival for previously untreated liver cancer patients, Exelixis notes that it's unlikely to demonstrate a statistically significant improvement in overall survival by trial completion in early 2022.\nWhile this might sound like a disappointment, it isn't. It's par for the course when developing blockbuster cancer drugs. Cabometyx failed in a late-stage study targeted at prostate cancer patients in 2014 but has since bounced back to gain numerous approvals. With this key drug being examined in close to six dozen clinical trials, label expansion opportunities remain abundant for Exelixis.\nImage source: Getty Images.\nBroadcom\nStepping outside the healthcare arena for the moment, semiconductor solutions provider Broadcom (NASDAQ:AVGO) is a perfect stock to put $1,000 to work in for the fourth quarter. I say \"perfect,\" because Broadcom is at the center of two very sustainable growth trends.\nFirst, it's going to be a multiyear beneficiary of the rollout of 5G wireless infrastructure. A majority of Broadcom's revenue comes from wireless chips and other accessories found in smartphones. Because it's been a decade since consumers and businesses have benefited from an upgrade to wireless download speeds, the expectation is that we'll see a sustainable, multiyear device replacement cycle. This should allow Broadcom to lock in its orders months or years in advance.\nBut it's not just smartphones that should have investors excited about Broadcom. The pandemic has also accelerated the shift of enterprise and consumer data into the cloud. This means data center demand should be strong for a long time to come. Broadcom is a provider of connectivity and access chips used by enterprise data centers.\nThe icing on the cake here is that the company has grown its quarterly dividend by more than 5,000% in less than 11 years. Investors can collect a nearly 3% yield as they sit back and watch Broadcom's profitability climb.\nImage source: Getty Images.\nVertex Pharmaceuticals\nSimilar to Exelixis, specialty biotech stock Vertex Pharmaceuticals (NASDAQ:VRTX) offers the right blend of double-digit sales growth and insane value (a forward-year price-to-earnings ratio of only 14), which makes it a no-brainer buy for the fourth quarter.\nWhat allows Vertex to stand out is its overwhelming success in developing multiple generations of treatments for patients with cystic fibrosis (CF). CF is a genetic disease characterized by thick mucus production that can obstruct the pancreas and/or lungs. Vertex's latest treatment, combination therapy Trikafta, was approved five months ahead of the U.S. Food and Drug Administration's review date, and is pacing $5 billion in annual run-rate sales despite hitting pharmacy shelves less than two years ago.\nKeeping with the similarities to Exelixis, Vertex was hit hard twice over the past year after two separate experimental treatments targeting alpha-1 antitrypsin deficiency were discontinued in mid-stage trials. Nevertheless, Vertex has more than a half-dozen combined internal and out-licensed treatments in development for a variety of indications. Even though its CF franchise is well-protected from competition, the company is working on an expansive pipeline of products.\nAnd don't overlook Vertex's cash pile. It ended June with about $6.7 billion in cash and cash equivalents, which is more than enough to fuel internal development, fund novel partnerships, or make acquisitions.\nImage source: Getty Images.\nTeladoc Health\nLastly, buying shares of telemedicine kingpin Teladoc Health (NYSE:TDOC) would be a perfect use of $1,000 for the fourth quarter.\nWhen the pandemic hit, there's no sugarcoating that Teladoc was in the right place at the right time. With doctors wanting to keep potentially sick and high-risk people out of their offices, they regularly turned to virtual visit platforms, such as those offered by Teladoc. Last year, Teladoc handled almost 10.6 million visits, which was well over double the 4.14 million visits in 2019.\nSome skeptics have cautioned that Teladoc could be a one-hit wonder considering the worst of the pandemic may now be in the rearview mirror. However, this view overlooks the many lasting changes telemedicine brings to the table. It's far more convenient for patients, can allow doctors to keep better tabs on their chronic-care patients, and should result in better patient outcomes and lower total treatment costs for insurers. There's a reason Teladoc's annual sales growth averaged 74% in the six years leading up to the pandemic.\nTeladoc Health also acquired the nation's leading applied health signals company, Livongo Health, in the fourth quarter of 2020. Livongo leans on artificial intelligence to send tips to its chronic-care members to help them lead healthier lives. While most of Livongo' 715,000 chronic-care enrollees are diabetics, it aims to offer its services to those with weight management issues and hypertension, as well. In other words, we're watching the very early innings of a personalized care disruptor.","news_type":1},"isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":868040869,"gmtCreate":1632559503351,"gmtModify":1632657444478,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"I’m in my twenties, just&nbsp;started my career a year ago, started to learn about&nbsp;trading with small capital.&nbsp;Sometimes I wonder if it’s wise to trade&nbsp;such “expensive” stock? AMZN priced&nbsp;at close to&nbsp;$3.5k or 1 unit. $3.5k equivalent to&nbsp;approximately 4 units of&nbsp;TSLA.&nbsp;","listText":"I’m in my twenties, just&nbsp;started my career a year ago, started to learn about&nbsp;trading with small capital.&nbsp;Sometimes I wonder if it’s wise to trade&nbsp;such “expensive” stock? AMZN priced&nbsp;at close to&nbsp;$3.5k or 1 unit. $3.5k equivalent to&nbsp;approximately 4 units of&nbsp;TSLA.&nbsp;","text":"I’m in my twenties, just started my career a year ago, started to learn about trading with small capital. Sometimes I wonder if it’s wise to trade such “expensive” stock? AMZN priced at close to $3.5k or 1 unit. $3.5k equivalent to approximately 4 units of TSLA.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/868040869","repostId":"2169615117","repostType":4,"repost":{"id":"2169615117","pubTimestamp":1632532001,"share":"https://www.laohu8.com/m/news/2169615117?lang=&edition=full","pubTime":"2021-09-25 09:06","market":"us","language":"en","title":"2 Expensive Stocks That Can Still Produce Great Returns in the Long Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2169615117","media":"Motley Fool","summary":"Even though these growth stocks are overpriced, they may still be worth buying today.","content":"<p>Valuation multiples can help compare stocks and provide ways for investors to identify value. But there can be a danger in focusing on them too much; if you only invested in stocks that traded at low earnings multiples, you could miss out on fast-growing businesses with lots of long-term potential.</p>\n<p>That's why an argument could be made that growth stocks like <b>Amazon&nbsp;</b>(NASDAQ:AMZN) and&nbsp;<b>Intuitive Surgical&nbsp;</b>(NASDAQ:ISRG), which aren't cheap by any stretch, may still deliver good returns for investors who hang on to these investments long enough.</p>\n<p><img src=\"https://static.tigerbbs.com/fcafb631d9483f8b901e77700427fa10\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\">Image source: Getty Images.</p>\n<h2>1. Intuitive Surgical</h2>\n<p>Healthcare stock Intuitive Surgical trades at a price-to-earnings ratio (or P/E) of 76. That's extremely high when you consider that the average holding in the <b>Health Care Select Sector SPDR Fund</b> trades at just 27 times its profits.&nbsp;Value investors may be tempted to skip over Intuitive Surgical given such a high valuation.</p>\n<p>But the robotic-assisted surgery company is still in its very early growth stages. Analysts from Market Research Future project that the surgical robotics market will grow at a compound annual growth rate of 17% until 2027. And by then, it will still be worth only $13.7 billion. Healthcare giant&nbsp;<b>Johnson &amp; Johnson&nbsp;</b>records more revenue in just a three-month period.</p>\n<p>Intuitive Surgical is a long-term play. It could take more than 10 years for this company to really take off and be anywhere near the top players in the healthcare industry. But it has been generating good numbers already. During the trailing 12 months, the company has reported earnings of $1.6 billion on sales of $5.2 billion for an impressive profit margin of more than 31%. That's far better than the 20% of revenue that Johnson &amp; Johnson has been banking as profit over the past year.</p>\n<p>Key to Intuitive Surgical's growth are its da Vinci systems, which help surgeons perform complex and delicate procedures, utilizing robotics. The pandemic has negatively impacted its business as hospitals have pushed off procedures. Yet for the quarter ended June 30, the company shipped 328 of its surgical systems -- an 84% increase from a year ago. And the number of da Vinci procedures was also up 68% from the prior-year period. That boosted Intuitive Surgical's revenue by 72% to $1.46 billion.</p>\n<p>Demand for the company's da Vinci systems looks to be strong, and that's why this could make for a promising growth stock to hold for many years to come.</p>\n<h2>2. Amazon</h2>\n<p>Online retail giant Amazon is never a cheap stock to own. Its P/E of 58 is a bit lower than it has been in previous years, but that's largely to do with the surge in consumer purchases during the pandemic -- which have given its profits a big boost. In the past, it wouldn't be uncommon for the stock to be trading at more than 100 times its earnings.</p>\n<p>In 2020, the company's net sales of $386 billion were more than double the $178 billion it reported just three years earlier. Doubling revenue for a company of Amazon's size is no small feat. What's even more impressive is that during that time, its bottom line skyrocketed from just $3 billion to more than $21 billion.</p>\n<p>And while Amazon has been diversifying its business to include its subscription-related products, Amazon Web Services, and the grocery business (through Whole Foods), the company's online stores and third-party seller services still make up more than 70% of its top line.</p>\n<p>The company's wide array of expertise and resources gives Amazon many ways it can enter new markets and segments. One of its most recent areas of interest has been healthcare. Last year, it launched Amazon Pharmacy, a delivery service to help customers stay on top of their prescriptions. There were also rumors earlier this year that the business would take it even a step further and launch physical pharmacies, potentially going up against retail pharmacy chains <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> </b>and&nbsp;<b>CVS Health</b>.</p>\n<p>For a business that has $90 billion in cash and marketable securities on its books as of June 30, Amazon can entertain any growth opportunity it wants. Amazon's stock will always command a premium as its business is synonymous with innovation. Given its dominance in the online world and many growth opportunities still out there, it is another stock that could be worth just buying and holding onto for many years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Expensive Stocks That Can Still Produce Great Returns in the Long Run</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Expensive Stocks That Can Still Produce Great Returns in the Long Run\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-25 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/24/2-expensive-stocks-that-can-still-produce-great-re/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Valuation multiples can help compare stocks and provide ways for investors to identify value. But there can be a danger in focusing on them too much; if you only invested in stocks that traded at low ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/24/2-expensive-stocks-that-can-still-produce-great-re/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISRG":"直觉外科公司","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/09/24/2-expensive-stocks-that-can-still-produce-great-re/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169615117","content_text":"Valuation multiples can help compare stocks and provide ways for investors to identify value. But there can be a danger in focusing on them too much; if you only invested in stocks that traded at low earnings multiples, you could miss out on fast-growing businesses with lots of long-term potential.\nThat's why an argument could be made that growth stocks like Amazon (NASDAQ:AMZN) and Intuitive Surgical (NASDAQ:ISRG), which aren't cheap by any stretch, may still deliver good returns for investors who hang on to these investments long enough.\nImage source: Getty Images.\n1. Intuitive Surgical\nHealthcare stock Intuitive Surgical trades at a price-to-earnings ratio (or P/E) of 76. That's extremely high when you consider that the average holding in the Health Care Select Sector SPDR Fund trades at just 27 times its profits. Value investors may be tempted to skip over Intuitive Surgical given such a high valuation.\nBut the robotic-assisted surgery company is still in its very early growth stages. Analysts from Market Research Future project that the surgical robotics market will grow at a compound annual growth rate of 17% until 2027. And by then, it will still be worth only $13.7 billion. Healthcare giant Johnson & Johnson records more revenue in just a three-month period.\nIntuitive Surgical is a long-term play. It could take more than 10 years for this company to really take off and be anywhere near the top players in the healthcare industry. But it has been generating good numbers already. During the trailing 12 months, the company has reported earnings of $1.6 billion on sales of $5.2 billion for an impressive profit margin of more than 31%. That's far better than the 20% of revenue that Johnson & Johnson has been banking as profit over the past year.\nKey to Intuitive Surgical's growth are its da Vinci systems, which help surgeons perform complex and delicate procedures, utilizing robotics. The pandemic has negatively impacted its business as hospitals have pushed off procedures. Yet for the quarter ended June 30, the company shipped 328 of its surgical systems -- an 84% increase from a year ago. And the number of da Vinci procedures was also up 68% from the prior-year period. That boosted Intuitive Surgical's revenue by 72% to $1.46 billion.\nDemand for the company's da Vinci systems looks to be strong, and that's why this could make for a promising growth stock to hold for many years to come.\n2. Amazon\nOnline retail giant Amazon is never a cheap stock to own. Its P/E of 58 is a bit lower than it has been in previous years, but that's largely to do with the surge in consumer purchases during the pandemic -- which have given its profits a big boost. In the past, it wouldn't be uncommon for the stock to be trading at more than 100 times its earnings.\nIn 2020, the company's net sales of $386 billion were more than double the $178 billion it reported just three years earlier. Doubling revenue for a company of Amazon's size is no small feat. What's even more impressive is that during that time, its bottom line skyrocketed from just $3 billion to more than $21 billion.\nAnd while Amazon has been diversifying its business to include its subscription-related products, Amazon Web Services, and the grocery business (through Whole Foods), the company's online stores and third-party seller services still make up more than 70% of its top line.\nThe company's wide array of expertise and resources gives Amazon many ways it can enter new markets and segments. One of its most recent areas of interest has been healthcare. Last year, it launched Amazon Pharmacy, a delivery service to help customers stay on top of their prescriptions. There were also rumors earlier this year that the business would take it even a step further and launch physical pharmacies, potentially going up against retail pharmacy chains Walgreens Boots Alliance and CVS Health.\nFor a business that has $90 billion in cash and marketable securities on its books as of June 30, Amazon can entertain any growth opportunity it wants. Amazon's stock will always command a premium as its business is synonymous with innovation. Given its dominance in the online world and many growth opportunities still out there, it is another stock that could be worth just buying and holding onto for many years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860346204,"gmtCreate":1632141245308,"gmtModify":1632802590780,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Malaysia pandemic 🏳️","listText":"Malaysia pandemic 🏳️","text":"Malaysia pandemic 🏳️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/860346204","repostId":"2168502577","repostType":4,"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":860343767,"gmtCreate":1632141082659,"gmtModify":1632802592476,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Appreciate the insight 🙏🏻Thank you&nbsp;","listText":"Appreciate the insight 🙏🏻Thank you&nbsp;","text":"Appreciate the insight 🙏🏻Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860343767","repostId":"1130418583","repostType":4,"repost":{"id":"1130418583","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1632138209,"share":"https://www.laohu8.com/m/news/1130418583?lang=&edition=full","pubTime":"2021-09-20 19:43","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1130418583","media":"Tiger Newspress","summary":"(Sept 20) U.S. stock futures sold off Monday morning, tracking declines in overseas equities as inve","content":"<p>(Sept 20)&nbsp;U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.</p>\n<p>At 07:47 a.m. ET,&nbsp;Dow futures sank by more than 600 points, or 1.79%, in early trading. S&amp;P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.</p>\n<p><img src=\"https://static.tigerbbs.com/b8c25019026526b24ae7ba8fd17ac289\" tg-width=\"1242\" tg-height=\"503\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>1)&nbsp;China Evergrande Group—&nbsp;Chinese property giant&nbsp;Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets.&nbsp;The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.</p>\n<p><b>2)&nbsp;<a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.</p>\n<p><b>3)&nbsp;<a href=\"https://laohu8.com/S/LPI\">Laredo</a> ,<a href=\"https://laohu8.com/S/OXY\">Occidental</a></b> — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&amp;P Oil &amp; Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.</p>\n<p><b>4)&nbsp;<a href=\"https://laohu8.com/S/CL\">Colgate-Palmolive</a></b> — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.</p>\n<p>5)&nbsp;JPMorgan,&nbsp;Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.</p>\n<p><b>6)&nbsp;<a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></b> — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.</p>\n<p><b>7)&nbsp;<a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> </b>— Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.</p>\n<p>Some investors believe this is just normal market action that can occur in September.</p>\n<p>“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.</p>\n<p>Other risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.</p>\n<p>Most commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-20 19:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(Sept 20)&nbsp;U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.</p>\n<p>At 07:47 a.m. ET,&nbsp;Dow futures sank by more than 600 points, or 1.79%, in early trading. S&amp;P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.</p>\n<p><img src=\"https://static.tigerbbs.com/b8c25019026526b24ae7ba8fd17ac289\" tg-width=\"1242\" tg-height=\"503\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Stocks making the biggest moves premarket</b></p>\n<p>1)&nbsp;China Evergrande Group—&nbsp;Chinese property giant&nbsp;Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets.&nbsp;The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.</p>\n<p><b>2)&nbsp;<a href=\"https://laohu8.com/S/PFE\">Pfizer</a></b> — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.</p>\n<p><b>3)&nbsp;<a href=\"https://laohu8.com/S/LPI\">Laredo</a> ,<a href=\"https://laohu8.com/S/OXY\">Occidental</a></b> — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&amp;P Oil &amp; Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.</p>\n<p><b>4)&nbsp;<a href=\"https://laohu8.com/S/CL\">Colgate-Palmolive</a></b> — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.</p>\n<p>5)&nbsp;JPMorgan,&nbsp;Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.</p>\n<p><b>6)&nbsp;<a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></b> — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.</p>\n<p><b>7)&nbsp;<a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a> </b>— Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.</p>\n<p>Some investors believe this is just normal market action that can occur in September.</p>\n<p>“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.</p>\n<p>Other risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.</p>\n<p>Most commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY":"标普500ETF",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1130418583","content_text":"(Sept 20) U.S. stock futures sold off Monday morning, tracking declines in overseas equities as investors nervously eyed the potential ripple effects of the default of a major Chinese real estate company and ongoing debates over the debt limit in Washington.\nAt 07:47 a.m. ET, Dow futures sank by more than 600 points, or 1.79%, in early trading. S&P 500 futures also dropped by more than 1%, adding to losses from last week. The CBOE Volatility Index, or Vix (^VIX), jumped by more than 30% as a confluence of concerns roiled markets.\n\nStocks making the biggest moves premarket\n1) China Evergrande Group— Chinese property giant Evergrande tumbled more than 10% on Hong Kong Stock Exchange, spooking Asian markets. The company has been scrambling to pay its suppliers, and warned investors twice in as many weeks that it could default on its debts. Last week Evergrande said its property sales will likely continue to drop significantly in September after declining for months.\n2) Pfizer — The pharmaceutical giantsaid Mondaythat trials showed its Covid vaccine was safe and effective when used in children ages 5 to 11. Pfizer and partner BioNTech said they would submit the results for approval “as soon as possible.” Shares of Pfizer were down about 1% in premarket trading.\n3) Laredo ,Occidental — Oil and energy stocks dipped in premarket trading on Monday. The SPDR S&P Oil & Gas Exploration ETF is down more than 3% in early trading, on pace for its 3rd straight negative session. Laredo Petroleum is down more than 8%, Callon Petroleum is down roughly 6%, and Occidental Petroleum is down nearly 5%. The losses came as crude oil fell on fears of a global economic slowdown tied to the China property market.\n4) Colgate-Palmolive — The consumer staples stock wasupgradedto buy from hold by Deutsche Bank on Sunday. The investment firm said that Colgate’s difficulties with inflation and in some international markets was already priced in to its stock.\n5) JPMorgan, Bank of America— Bank stocks slid in unison amid a decline in bond yields on slowdown fears. Investors flocked to Treasurys for safety as the stock market is set for its biggest sell-off in months. Big bank stocks took a hit as the falling rates may crimp profits. Bank of America and JPMorgan Chase were each down more than 2% in premarket trading. Citizens Financial Group dropped 3%, while Citigroup declined 2.5%.\n6) AstraZeneca Plc — The United Kingdom-based pharmaceutical company announced on Monday that its breast cancer drug Enhertu showed positive results in a phase-three trial. Shares of the company were up more than 1% in premarket trading.\n7) ARK Innovation ETF — Cathie Wood’s ARK Innovation ETF is down 2.75% in the premarket, on pace to snap a 3-day winning streak. Compugen, DraftKings, Coinbase and Square are so of the ETF’s biggest losers this morning.\nSome investors believe this is just normal market action that can occur in September.\n“The reasons for drop this morning are the same as last week: China concerns (Evergrande, regulation, COVID), Fed tapering and possible tax hikes, but nothing new occurred this weekend to justify this mornings’ declines,” Tom Essaye, founder of Sevens Report, said in a note.\nOther risky assets declined on Monday.Bitcoinlost 8% tobelow $44,000.\nMost commodities were in the red.Goldwas among the few assets in the green, adding 0.5% to $1,760.","news_type":1},"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887593855,"gmtCreate":1632059211377,"gmtModify":1632803090001,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887593855","repostId":"1187895428","repostType":4,"repost":{"id":"1187895428","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1631805240,"share":"https://www.laohu8.com/m/news/1187895428?lang=&edition=full","pubTime":"2021-09-16 23:14","market":"us","language":"en","title":"Why Palantir Shares Are Trading Higher Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1187895428","media":"Benzinga","summary":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.The average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over","content":"<p><b>Palantir Technologies</b>&nbsp;is trading higher Thursday morning on above-average volume&nbsp;amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million&nbsp;over a 100-day period. Palantir's daily trading volume was already approaching 30&nbsp;million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects&nbsp;revenue growth of 30% or greater&nbsp;through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Palantir Shares Are Trading Higher Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Palantir Shares Are Trading Higher Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-09-16 23:14</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Palantir Technologies</b>&nbsp;is trading higher Thursday morning on above-average volume&nbsp;amid increased retail investor interest in the stock on social media.</p>\n<p><img src=\"https://static.tigerbbs.com/8ab0249e536a33b1fd6c306c047556b8\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n<p>The average session volume is about 42 million&nbsp;over a 100-day period. Palantir's daily trading volume was already approaching 30&nbsp;million less than an hour into trading Thursday.</p>\n<p>Palantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.</p>\n<p>Palantir has continually said that it expects&nbsp;revenue growth of 30% or greater&nbsp;through 2025.</p>\n<p>The company makes products for human-driven analysis of real-world data.</p>\n<p><b>PLTR Price Action:</b>Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.</p>\n<p>The stock was up 5% at $28.45 at time of publication.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1187895428","content_text":"Palantir Technologies is trading higher Thursday morning on above-average volume amid increased retail investor interest in the stock on social media.\n\nThe average session volume is about 42 million over a 100-day period. Palantir's daily trading volume was already approaching 30 million less than an hour into trading Thursday.\nPalantir was one the top two trending stocks on Stocktwits at publication time. The stock was among the top five most mentioned stocks on the subreddit r/wallstreetbets over the last 24 hours.\nPalantir has continually said that it expects revenue growth of 30% or greater through 2025.\nThe company makes products for human-driven analysis of real-world data.\nPLTR Price Action:Palantir has traded as high as $45 and as low as $8.90 over a 52-week period.\nThe stock was up 5% at $28.45 at time of publication.","news_type":1},"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887599912,"gmtCreate":1632058969336,"gmtModify":1632803091333,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Cheers towards financial freedom 💰","listText":"Cheers towards financial freedom 💰","text":"Cheers towards financial freedom 💰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/887599912","repostId":"1198486138","repostType":4,"repost":{"id":"1198486138","pubTimestamp":1632023224,"share":"https://www.laohu8.com/m/news/1198486138?lang=&edition=full","pubTime":"2021-09-19 11:47","market":"us","language":"en","title":"7 ways men live without working in America","url":"https://stock-news.laohu8.com/highlight/detail?id=1198486138","media":"Yahoo Finance","summary":"How do they live? What are they doing for money? ","content":"<p>Almost one-third of all working-age men in America aren’t doing diddly-squat. They don’t have a job, and they aren’t looking for one either. One-third of all working-age men. That’s almost 30 million people!</p>\n<p>How do they live? What are they doing for money? To me, this is one of the great mysteries of our time.</p>\n<p>I’m certainly not the first person to make note of this shocking statistic. You’ve heard people bemoaning this \"labor participation rate,\" which is simply the number of working-age men (usually counted as ages 16 to 64) not working or not looking for work, as a percentage of the overall labor force.</p>\n<p>It’s true that the pandemic, which of course produced a number of factors that made working more difficult never mind dangerous, pushed the labor participation rate to a record low. But the fact that millions of American males have not been working precedes COVID-19 by decades. In fact, the participation rate for men peaked at 87.4% in October 1949 and has been dropping steadily ever since. It now stands at 67.7%.</p>\n<p>As a business journalist for a good portion of those 70-plus years, I’ve looked at thousands of charts and graphs in my life, and I have to say this one is as jaw dropping as it is vexing:</p>\n<p><img src=\"https://static.tigerbbs.com/056158b8fa7157238c3d1521dd05c02e\" tg-width=\"705\" tg-height=\"259\" referrerpolicy=\"no-referrer\">Chart of the U.S. labor force participation rate for men over time, courtesy of the St. Louis Federal Reserve</p>\n<p>Economists, sociologists, politicians, and cable news pundits each have their pet factors to explain the groundswell of non-work. But after digging down here, I’ve concluded there are many different forces at play. That’s what I want to explore today, which is: how men can live in America without working.</p>\n<p>I’m not talking about why men have lost their jobs — factories closing, layoffs, automation, outsourcing jobs overseas, even perhaps women entering the workforce, (in fact, the participation rate by women over the same time period is way up). What I want to get at is how they’re living without holding a \"real\" job, and by that I mean doing work where one reports income to the IRS, pays taxes and Social Security, etc.</p>\n<p>It’s important to note that every man in this group has his own story. They range from mentally ill homeless men who desperately need our help, to the I’m-doing-just-fine-thank-you-very-much, retired early, and former Silicon Valley coder. And there are infinite scenarios in between those two extremes, including, for instance, the many men who have chosen to bestay-at-home dadswhile their spouses work.</p>\n<p>It’s also the case that some men in this group may be unemployed and not seeking work because they’ve given up looking just for now — perhaps waiting for COVID to abate — and will start the search again soon. Here too, society needs to help.</p>\n<p>Still, none of this explains decade after decade of falling male employment.</p>\n<p>To that end, here to my mind are seven ways men are living without working in America:</p>\n<p><b>-Unemployment insurance</b></p>\n<p>Let’s start with this one because it’s a hot button issue. Conservatives and some liberals too have made the claim that state unemployment aid, coupled with $600 a week from the CARES Act, which was rolled out in March 2020, have reduced men’s need to work. (There are actually a variety of social programs at play,spelled out nicely hereby think tank The Century Foundation, which estimates that overall these programs have pumped $800 billion in the economy.) We’ll be getting a good read on whether all this relief did suppress employment now that CARES aid ended for some 7.5 million Americans earlier this month. But as Yahoo Finance’s Denitsa Tsekova reportedhereandhere, states that ended federal aid programs early didn’t see big increases in employment. That may mean these payments really weren’t enough to live off, or not enough to live off by themselves, which speaks to men looking to a combination of sources, like under the table income or family support and possibly some savings (see below).</p>\n<p><b>-Early retirement, pensions, disability and lawsuits</b></p>\n<p>Admittedly, this is a bit of a hodgepodge. And as is the case with many of these categories, hard data is tough to come by, but it is the case that millions of men under 64 are at least partly living off of pensions and 401(k)s. This would include everything from C-suite executives to union members. And don’t forget municipal workers, who make up almost 14% of the U.S. workforce. According to the U.S. Census Bureau, there are some 6,000 public sector retirement systems in the U.S.Collectively these plans have $4.5 trillion in assets,with 14.7 million working members and 11.2 million retirees. The plans distribute $323 billion in benefits annually, and again, some to men who are younger than 64. In fact in almost two-thirds of these plans,if you started working at 25, you max out at 57, a real inducement to stop working — at least at that job of course.</p>\n<p><img src=\"https://static.tigerbbs.com/53e26b293f8a939a54b78315c3375a18\" tg-width=\"705\" tg-height=\"467\" referrerpolicy=\"no-referrer\">Volunteers load cars with turkeys and other food assistance for laid off Walt Disney World cast members and others at a food distribution event on December 12, 2020 in Orlando, Florida. (Photo by Paul Hennessy/NurPhoto via Getty Images)More</p>\n<p>There’s also disability insurance from the Social Security Administration that is beingpaid to some 9 million Americanswhomay receive payments many years before retirement age. That's why I am including disability here, but not plain vanilla Social Security, which you can’t receive until age 62. The maximum disability benefit amount you can receive each month is currently $3,148. (However, the average beneficiary receives about $1,277 per month, according to the law group Social Security Disability Advocates.) Overall, it looks like theSSA pays out some $130 billion in disability annually.That’s not nothing. Then there’s money paid out in medical malpractice each year, smaller true, but stillestimated to be in excess of $3 billion.And don't forgetpayments from legal settlements and class action lawsuits.</p>\n<p>You argue all day about the right or wrong when it comes to these payouts, but the fact is many of them didn’t exist, or not at this magnitude, decades ago.</p>\n<p><b>-Savings, trading stocks, and bitcoin</b></p>\n<p>Consider now men are living off savings, or from money made in the market or maybe even selling NFTs. How many is it exactly? Who knows, but quite a few for sure. First off, Americans on average do have some money in the bank. Savings as a percentage of disposable income,according to the Federal Reserve of Kansas City,hit a record high of 33% in the spring of 2020 and is still at 14%, or nearly twice as high as it was prior to the pandemic.</p>\n<p>And according to arecent survey by Northwestern Mutual,average personal savings are up over 10% compared to last year, from $65,900 last year to $73,100. Average retirement savings increased 13%, from $87,500 last year to $98,800 today. So there’s that.</p>\n<p>Next let’s look at investing — first stocks. It is not irrelevant to this narrative that the S&amp;P 500 has climbed from 2,480 on March 12, 2020 — the day after the World Health Organization declared COVID a pandemic— to 4,441 today, or almost 80%. That’s a huge gain. Much of the action of course has been retail investors and the meme stock boom, as millions of American males stuck at home with nothing to do all day for the past 18 months passed the time trading stocks. Credit Suisse estimates that since the beginning of 2020, “retail trading as a share of overall market activityhas nearly doubledfrom between 15% and 18% to over 30%,” as CNBC reported. How many men were doing this and supporting themselves? Unclear, but upstart trading platform Robinhood (HOOD) — the broker dealer of choice for many of these new investors — reported that it had22.5 million funded user accountslast month, up from 7.2 million in March of 2020. Let’s just say 15 million new accounts is quite a number.</p>\n<p>Now crypto. You can laugh all you want, but the simple fact is that theprice of bitcoinis up from $4,861 on March 12, 2000 to $47,763 today, or basically up 10X, (and remember it even hit $64,888.99 this spring). Back to Robinhood, which according to The New York Times, also reported last month that “revenue from cryptocurrency trading fees totaled $233 million, a nearly 50-fold jump from $5 million a year earlier.” (And those are just fees off the trades, mind you.) Bottom line: Folks have made money here. (Of course these guys should be paying taxes on all those stock and crypto gains.)</p>\n<p><img src=\"https://static.tigerbbs.com/809084435ffdcbc0695311d158bb7a98\" tg-width=\"705\" tg-height=\"470\" referrerpolicy=\"no-referrer\">Robinhood Markets, Inc. CEO and co-founder Vlad Tenev and co-founder Baiju Bhatt pose with Robinhood signage on Wall Street after the company's IPO in New York City, U.S., July 29, 2021. REUTERS/Andrew Kelly<b>-Working for cash, aka the under-the-table economy</b></p>\n<p>This one is very tough to measure, too.A study by the Federal Reserve of St. Louisestimates that the average size of the “informal economy” in developed countries is 13% of GDP. Honestly, that could be off by many percentage points, but just to give you a ballpark, GDP in the U.S. this year is about $22 trillion. So 13% of that is $2.86 trillion. As it turns out, $2 trillion-plus, is a number that has been thrown around quite a bit (hereandherefor instance) when it comes to estimating the size of the cash economy in the U.S. Even if half that money is paid out to women, that still leaves, say, $1 trillion dollars being made by men in this country off the books. That’s a big chunk of change. Are more people than ever working for cash these days? Again, another question that’s impossible to answer. I would bet it’s not fewer. For example, my electrician Luis just told me he can’t get anyone to work for him anymore — they all want to get paid in cash.</p>\n<p><b>-Living off family members</b></p>\n<p>Just to take one facet,the Pew Research Center reportedlast year that the pandemic “has pushed millions of Americans, especially young adults, to move in with family members. The share of 18- to 29-year-olds living with their parents has become a majority since U.S. coronavirus cases began spreading [in early 2020], surpassing the previous peak during the Great Depression era. In July, 52% of young adults resided with one or both of their parents, up from 47% in February.” How many of these individuals are males living rent free (and sharing food too), which maybe means they don’t have to work? Who knows, but some. Ditto for males who have moved in with in-laws or siblings. And again, many men are choosing to stay home and take care of kids while their spouses work.</p>\n<p><b>-Illegal work</b></p>\n<p>Front and center here is selling illegal drugs. Sadly, business looks to be booming, that is if overdoses are any sort of measure.According to the Washington Post, overdose deaths hit 93,000 last year, up a stunning 30% from 2019. Most of the overdoses were attributed to opioids; heroin, synthetic opioids like OxyContin and in particular Fentanyl. (This despite drug dealers facingsupply chain issuesduring COVID.) How many Americans are in this business and who are they? A number is almost impossible to come by here, but as for who they are,a government report on drug trafficking arrestsfrom five years ago notes that ”the majority of drug trafficking offenders were male (84.9%), the average age of these offenders at sentencing was 36 years, 70% were United States citizens (although this rate varied substantially depending on the type of drug involved), and that almost half (49.4%) of drug traffickers had little or no prior criminal history.” How big a business is selling drugs in America? Could beas much as $100 billion.I think it’s fair to say that a market that size requires many thousands of employees.</p>\n<p>What about other types of crime and criminals, everything from robbers and thieves to prostitutes and pimps? To that point there aresome 2 million people incarcerated in the U.S.right now. (We have the highest absolute number and the highest per capita on the planet, and holdsome 25% of the world's total prisoners, according to the ACLU.) Being in prison is another way of living in America without working, I guess. But not counting those locked up, how many bad guys are out there on the street? Conservatively, it has to be thousands and thousands, and speaking to this story, they're all doing their thing and not participating in the labor force.</p>\n<p><img src=\"https://static.tigerbbs.com/3f8f4b3e6a5aa97a10f5c7bb22dec1d7\" tg-width=\"705\" tg-height=\"470\" referrerpolicy=\"no-referrer\">ORLEANS, MASSACHUSETTS - JULY 10: A man holds onto a clamming rake while clamming at low tide July 10, 2021 in Town Cove, Orleans, Massachusetts. He filled a bushel basket of cherry stone clams. (Photo by Robert Nickelsberg/Getty Images)More<b>-Living off the land</b></p>\n<p>This would include gardening, fishing, hunting, clamming, berrying, and just general foraging. The numbers here seem to be climbing. Here for instancefrom The Guardian:</p>\n<p>“Fishing and huntinglicense sales increased 10%in California during the pandemic, reversing years of decline. Clamming has grown in popularity for several reasons: people are looking for safe activities to do outdoors, but also some are clamming for subsistence and trying to get money from selling the shellfish (which is illegal without a commercial license).”</p>\n<p>Ditto for Washington state, according to The Spokesman-Review:</p>\n<p>“From the start of the 2020 licensing year in May through Dec. 31, WDFW [Washington Department of Fish and Wildlife] sold nearly 45,000 more fishing licenses and 12,000 more hunting licenses than 2019. The number of new license holders — defined as someone who hadn’t purchased one for the previous five years — went up 16% for fishing licenses and almost 40% for hunters.”</p>\n<p>As for growing vegetables in home gardens, yes, it is up, way up too. Even before the pandemic, there were estimates thata third of American families grew vegetables.Now this,NPRreported last year:</p>\n<p>“‘We're being flooded with vegetable orders,’ says George Ball, executive chairman of the Burpee Seed Company, based in Warminster, Penn.</p>\n<p>Ball says he has noticed spikes in seed sales during bad times: the stock market crash of 1987, the dot com bubble burst of 2000, and he remembers the two oil crises of the 1970s from his childhood. But he says he has not seen a spike this large and widespread.</p>\n<p>So there you have it. It’s a whole range of ways and means, behaviors and experiences. I’m sure I missed some, too. Again, some non-working men are in dire straits and need our help. Others are living non-working lives without burdening society or others, such as a fireman on early retirement (though some argue municipal employee pensions are too high), or an investor who made a ton of money in the market and called it quits, or maybe a wilderness guy living off the land in Alaska.</p>\n<p>And some non-working men are not playing fair. Like getting paid under the table, fudging insurance claims or social programs. Some freeload off relatives. And some engage in overtly illegal behavior like boosting branded goods from chain stores to sell online or dealing heroin.</p>\n<p>I would imagine that more than a few of these men create a portfolio of sources, though I’m not sure they really think of it that way. Take for example a hypothetical guy in a rural area who lives with his grandmother rent free, (he does help her with the garden some). This guy also does some cash carpentry work, hunts for game, gets some food off his ex-wife’s WIC and helps his brother sell some weed. Can you get by this way? Some men probably are. Is this the new American way? For some men it probably is.</p>\n<p>That example perhaps, and to be sure of all of the above, I think go a long way toward explaining that chart from the beginning of the story, the one that shows the labor participation rate falling off a cliff over the past seven decades. And speaking of charts, another striking one came to mind when I was writing this, which I put here below. It shows U.S. GDP over the same time period as the labor participation rate.</p>\n<p><img src=\"https://static.tigerbbs.com/0f197be5c6c11483ec906a1757293e4d\" tg-width=\"705\" tg-height=\"259\" referrerpolicy=\"no-referrer\">Chart of the U.S. Gross Domestic Product over time, courtesy of the St. Louis Federal Reserve</p>\n<p>Of course, the line on this GDP chart is inversely correlated with the line on the labor participation graph. And I think there is a relationship between the two. Which is to say, the wealthier our nation has become over the decades, the less men are working. Fact is there is just a ton of money sloshing around in our country. And men seem to be able to get their hands on it, whether obtained legally, borrowed, leached off of or stolen.</p>\n<p>It seems like working legally to provide for yourself in America is really just one option these days.</p>\n<p><b><i>This article was featured in a Saturday edition of the Morning Brief on September 18, 2021. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET.Subscribe</i></b></p>\n<p><i>Andy Serwer is editor-in-chief of Yahoo Finance. Follow him on Twitter:@serwer</i></p>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 ways men live without working in America</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 ways men live without working in America\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-19 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/7-ways-men-live-without-working-in-america-092147068.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Almost one-third of all working-age men in America aren’t doing diddly-squat. They don’t have a job, and they aren’t looking for one either. One-third of all working-age men. That’s almost 30 million ...</p>\n\n<a href=\"https://finance.yahoo.com/news/7-ways-men-live-without-working-in-america-092147068.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/020219c8820f9fc9f11979454ce1b1c6","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/7-ways-men-live-without-working-in-america-092147068.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198486138","content_text":"Almost one-third of all working-age men in America aren’t doing diddly-squat. They don’t have a job, and they aren’t looking for one either. One-third of all working-age men. That’s almost 30 million people!\nHow do they live? What are they doing for money? To me, this is one of the great mysteries of our time.\nI’m certainly not the first person to make note of this shocking statistic. You’ve heard people bemoaning this \"labor participation rate,\" which is simply the number of working-age men (usually counted as ages 16 to 64) not working or not looking for work, as a percentage of the overall labor force.\nIt’s true that the pandemic, which of course produced a number of factors that made working more difficult never mind dangerous, pushed the labor participation rate to a record low. But the fact that millions of American males have not been working precedes COVID-19 by decades. In fact, the participation rate for men peaked at 87.4% in October 1949 and has been dropping steadily ever since. It now stands at 67.7%.\nAs a business journalist for a good portion of those 70-plus years, I’ve looked at thousands of charts and graphs in my life, and I have to say this one is as jaw dropping as it is vexing:\nChart of the U.S. labor force participation rate for men over time, courtesy of the St. Louis Federal Reserve\nEconomists, sociologists, politicians, and cable news pundits each have their pet factors to explain the groundswell of non-work. But after digging down here, I’ve concluded there are many different forces at play. That’s what I want to explore today, which is: how men can live in America without working.\nI’m not talking about why men have lost their jobs — factories closing, layoffs, automation, outsourcing jobs overseas, even perhaps women entering the workforce, (in fact, the participation rate by women over the same time period is way up). What I want to get at is how they’re living without holding a \"real\" job, and by that I mean doing work where one reports income to the IRS, pays taxes and Social Security, etc.\nIt’s important to note that every man in this group has his own story. They range from mentally ill homeless men who desperately need our help, to the I’m-doing-just-fine-thank-you-very-much, retired early, and former Silicon Valley coder. And there are infinite scenarios in between those two extremes, including, for instance, the many men who have chosen to bestay-at-home dadswhile their spouses work.\nIt’s also the case that some men in this group may be unemployed and not seeking work because they’ve given up looking just for now — perhaps waiting for COVID to abate — and will start the search again soon. Here too, society needs to help.\nStill, none of this explains decade after decade of falling male employment.\nTo that end, here to my mind are seven ways men are living without working in America:\n-Unemployment insurance\nLet’s start with this one because it’s a hot button issue. Conservatives and some liberals too have made the claim that state unemployment aid, coupled with $600 a week from the CARES Act, which was rolled out in March 2020, have reduced men’s need to work. (There are actually a variety of social programs at play,spelled out nicely hereby think tank The Century Foundation, which estimates that overall these programs have pumped $800 billion in the economy.) We’ll be getting a good read on whether all this relief did suppress employment now that CARES aid ended for some 7.5 million Americans earlier this month. But as Yahoo Finance’s Denitsa Tsekova reportedhereandhere, states that ended federal aid programs early didn’t see big increases in employment. That may mean these payments really weren’t enough to live off, or not enough to live off by themselves, which speaks to men looking to a combination of sources, like under the table income or family support and possibly some savings (see below).\n-Early retirement, pensions, disability and lawsuits\nAdmittedly, this is a bit of a hodgepodge. And as is the case with many of these categories, hard data is tough to come by, but it is the case that millions of men under 64 are at least partly living off of pensions and 401(k)s. This would include everything from C-suite executives to union members. And don’t forget municipal workers, who make up almost 14% of the U.S. workforce. According to the U.S. Census Bureau, there are some 6,000 public sector retirement systems in the U.S.Collectively these plans have $4.5 trillion in assets,with 14.7 million working members and 11.2 million retirees. The plans distribute $323 billion in benefits annually, and again, some to men who are younger than 64. In fact in almost two-thirds of these plans,if you started working at 25, you max out at 57, a real inducement to stop working — at least at that job of course.\nVolunteers load cars with turkeys and other food assistance for laid off Walt Disney World cast members and others at a food distribution event on December 12, 2020 in Orlando, Florida. (Photo by Paul Hennessy/NurPhoto via Getty Images)More\nThere’s also disability insurance from the Social Security Administration that is beingpaid to some 9 million Americanswhomay receive payments many years before retirement age. That's why I am including disability here, but not plain vanilla Social Security, which you can’t receive until age 62. The maximum disability benefit amount you can receive each month is currently $3,148. (However, the average beneficiary receives about $1,277 per month, according to the law group Social Security Disability Advocates.) Overall, it looks like theSSA pays out some $130 billion in disability annually.That’s not nothing. Then there’s money paid out in medical malpractice each year, smaller true, but stillestimated to be in excess of $3 billion.And don't forgetpayments from legal settlements and class action lawsuits.\nYou argue all day about the right or wrong when it comes to these payouts, but the fact is many of them didn’t exist, or not at this magnitude, decades ago.\n-Savings, trading stocks, and bitcoin\nConsider now men are living off savings, or from money made in the market or maybe even selling NFTs. How many is it exactly? Who knows, but quite a few for sure. First off, Americans on average do have some money in the bank. Savings as a percentage of disposable income,according to the Federal Reserve of Kansas City,hit a record high of 33% in the spring of 2020 and is still at 14%, or nearly twice as high as it was prior to the pandemic.\nAnd according to arecent survey by Northwestern Mutual,average personal savings are up over 10% compared to last year, from $65,900 last year to $73,100. Average retirement savings increased 13%, from $87,500 last year to $98,800 today. So there’s that.\nNext let’s look at investing — first stocks. It is not irrelevant to this narrative that the S&P 500 has climbed from 2,480 on March 12, 2020 — the day after the World Health Organization declared COVID a pandemic— to 4,441 today, or almost 80%. That’s a huge gain. Much of the action of course has been retail investors and the meme stock boom, as millions of American males stuck at home with nothing to do all day for the past 18 months passed the time trading stocks. Credit Suisse estimates that since the beginning of 2020, “retail trading as a share of overall market activityhas nearly doubledfrom between 15% and 18% to over 30%,” as CNBC reported. How many men were doing this and supporting themselves? Unclear, but upstart trading platform Robinhood (HOOD) — the broker dealer of choice for many of these new investors — reported that it had22.5 million funded user accountslast month, up from 7.2 million in March of 2020. Let’s just say 15 million new accounts is quite a number.\nNow crypto. You can laugh all you want, but the simple fact is that theprice of bitcoinis up from $4,861 on March 12, 2000 to $47,763 today, or basically up 10X, (and remember it even hit $64,888.99 this spring). Back to Robinhood, which according to The New York Times, also reported last month that “revenue from cryptocurrency trading fees totaled $233 million, a nearly 50-fold jump from $5 million a year earlier.” (And those are just fees off the trades, mind you.) Bottom line: Folks have made money here. (Of course these guys should be paying taxes on all those stock and crypto gains.)\nRobinhood Markets, Inc. CEO and co-founder Vlad Tenev and co-founder Baiju Bhatt pose with Robinhood signage on Wall Street after the company's IPO in New York City, U.S., July 29, 2021. REUTERS/Andrew Kelly-Working for cash, aka the under-the-table economy\nThis one is very tough to measure, too.A study by the Federal Reserve of St. Louisestimates that the average size of the “informal economy” in developed countries is 13% of GDP. Honestly, that could be off by many percentage points, but just to give you a ballpark, GDP in the U.S. this year is about $22 trillion. So 13% of that is $2.86 trillion. As it turns out, $2 trillion-plus, is a number that has been thrown around quite a bit (hereandherefor instance) when it comes to estimating the size of the cash economy in the U.S. Even if half that money is paid out to women, that still leaves, say, $1 trillion dollars being made by men in this country off the books. That’s a big chunk of change. Are more people than ever working for cash these days? Again, another question that’s impossible to answer. I would bet it’s not fewer. For example, my electrician Luis just told me he can’t get anyone to work for him anymore — they all want to get paid in cash.\n-Living off family members\nJust to take one facet,the Pew Research Center reportedlast year that the pandemic “has pushed millions of Americans, especially young adults, to move in with family members. The share of 18- to 29-year-olds living with their parents has become a majority since U.S. coronavirus cases began spreading [in early 2020], surpassing the previous peak during the Great Depression era. In July, 52% of young adults resided with one or both of their parents, up from 47% in February.” How many of these individuals are males living rent free (and sharing food too), which maybe means they don’t have to work? Who knows, but some. Ditto for males who have moved in with in-laws or siblings. And again, many men are choosing to stay home and take care of kids while their spouses work.\n-Illegal work\nFront and center here is selling illegal drugs. Sadly, business looks to be booming, that is if overdoses are any sort of measure.According to the Washington Post, overdose deaths hit 93,000 last year, up a stunning 30% from 2019. Most of the overdoses were attributed to opioids; heroin, synthetic opioids like OxyContin and in particular Fentanyl. (This despite drug dealers facingsupply chain issuesduring COVID.) How many Americans are in this business and who are they? A number is almost impossible to come by here, but as for who they are,a government report on drug trafficking arrestsfrom five years ago notes that ”the majority of drug trafficking offenders were male (84.9%), the average age of these offenders at sentencing was 36 years, 70% were United States citizens (although this rate varied substantially depending on the type of drug involved), and that almost half (49.4%) of drug traffickers had little or no prior criminal history.” How big a business is selling drugs in America? Could beas much as $100 billion.I think it’s fair to say that a market that size requires many thousands of employees.\nWhat about other types of crime and criminals, everything from robbers and thieves to prostitutes and pimps? To that point there aresome 2 million people incarcerated in the U.S.right now. (We have the highest absolute number and the highest per capita on the planet, and holdsome 25% of the world's total prisoners, according to the ACLU.) Being in prison is another way of living in America without working, I guess. But not counting those locked up, how many bad guys are out there on the street? Conservatively, it has to be thousands and thousands, and speaking to this story, they're all doing their thing and not participating in the labor force.\nORLEANS, MASSACHUSETTS - JULY 10: A man holds onto a clamming rake while clamming at low tide July 10, 2021 in Town Cove, Orleans, Massachusetts. He filled a bushel basket of cherry stone clams. (Photo by Robert Nickelsberg/Getty Images)More-Living off the land\nThis would include gardening, fishing, hunting, clamming, berrying, and just general foraging. The numbers here seem to be climbing. Here for instancefrom The Guardian:\n“Fishing and huntinglicense sales increased 10%in California during the pandemic, reversing years of decline. Clamming has grown in popularity for several reasons: people are looking for safe activities to do outdoors, but also some are clamming for subsistence and trying to get money from selling the shellfish (which is illegal without a commercial license).”\nDitto for Washington state, according to The Spokesman-Review:\n“From the start of the 2020 licensing year in May through Dec. 31, WDFW [Washington Department of Fish and Wildlife] sold nearly 45,000 more fishing licenses and 12,000 more hunting licenses than 2019. The number of new license holders — defined as someone who hadn’t purchased one for the previous five years — went up 16% for fishing licenses and almost 40% for hunters.”\nAs for growing vegetables in home gardens, yes, it is up, way up too. Even before the pandemic, there were estimates thata third of American families grew vegetables.Now this,NPRreported last year:\n“‘We're being flooded with vegetable orders,’ says George Ball, executive chairman of the Burpee Seed Company, based in Warminster, Penn.\nBall says he has noticed spikes in seed sales during bad times: the stock market crash of 1987, the dot com bubble burst of 2000, and he remembers the two oil crises of the 1970s from his childhood. But he says he has not seen a spike this large and widespread.\nSo there you have it. It’s a whole range of ways and means, behaviors and experiences. I’m sure I missed some, too. Again, some non-working men are in dire straits and need our help. Others are living non-working lives without burdening society or others, such as a fireman on early retirement (though some argue municipal employee pensions are too high), or an investor who made a ton of money in the market and called it quits, or maybe a wilderness guy living off the land in Alaska.\nAnd some non-working men are not playing fair. Like getting paid under the table, fudging insurance claims or social programs. Some freeload off relatives. And some engage in overtly illegal behavior like boosting branded goods from chain stores to sell online or dealing heroin.\nI would imagine that more than a few of these men create a portfolio of sources, though I’m not sure they really think of it that way. Take for example a hypothetical guy in a rural area who lives with his grandmother rent free, (he does help her with the garden some). This guy also does some cash carpentry work, hunts for game, gets some food off his ex-wife’s WIC and helps his brother sell some weed. Can you get by this way? Some men probably are. Is this the new American way? For some men it probably is.\nThat example perhaps, and to be sure of all of the above, I think go a long way toward explaining that chart from the beginning of the story, the one that shows the labor participation rate falling off a cliff over the past seven decades. And speaking of charts, another striking one came to mind when I was writing this, which I put here below. It shows U.S. GDP over the same time period as the labor participation rate.\nChart of the U.S. Gross Domestic Product over time, courtesy of the St. Louis Federal Reserve\nOf course, the line on this GDP chart is inversely correlated with the line on the labor participation graph. And I think there is a relationship between the two. Which is to say, the wealthier our nation has become over the decades, the less men are working. Fact is there is just a ton of money sloshing around in our country. And men seem to be able to get their hands on it, whether obtained legally, borrowed, leached off of or stolen.\nIt seems like working legally to provide for yourself in America is really just one option these days.\nThis article was featured in a Saturday edition of the Morning Brief on September 18, 2021. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET.Subscribe\nAndy Serwer is editor-in-chief of Yahoo Finance. Follow him on Twitter:@serwer","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887064786,"gmtCreate":1631946225845,"gmtModify":1632805137073,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Awesome!&nbsp;","listText":"Awesome!&nbsp;","text":"Awesome!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887064786","repostId":"1171574345","repostType":4,"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":868040869,"gmtCreate":1632559503351,"gmtModify":1632657444478,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"I’m in my twenties, just&nbsp;started my career a year ago, started to learn about&nbsp;trading with small capital.&nbsp;Sometimes I wonder if it’s wise to trade&nbsp;such “expensive” stock? AMZN priced&nbsp;at close to&nbsp;$3.5k or 1 unit. $3.5k equivalent to&nbsp;approximately 4 units of&nbsp;TSLA.&nbsp;","listText":"I’m in my twenties, just&nbsp;started my career a year ago, started to learn about&nbsp;trading with small capital.&nbsp;Sometimes I wonder if it’s wise to trade&nbsp;such “expensive” stock? AMZN priced&nbsp;at close to&nbsp;$3.5k or 1 unit. $3.5k equivalent to&nbsp;approximately 4 units of&nbsp;TSLA.&nbsp;","text":"I’m in my twenties, just started my career a year ago, started to learn about trading with small capital. Sometimes I wonder if it’s wise to trade such “expensive” stock? AMZN priced at close to $3.5k or 1 unit. $3.5k equivalent to approximately 4 units of TSLA.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":7,"repostSize":0,"link":"https://laohu8.com/post/868040869","repostId":"2169615117","repostType":4,"repost":{"id":"2169615117","pubTimestamp":1632532001,"share":"https://www.laohu8.com/m/news/2169615117?lang=&edition=full","pubTime":"2021-09-25 09:06","market":"us","language":"en","title":"2 Expensive Stocks That Can Still Produce Great Returns in the Long Run","url":"https://stock-news.laohu8.com/highlight/detail?id=2169615117","media":"Motley Fool","summary":"Even though these growth stocks are overpriced, they may still be worth buying today.","content":"<p>Valuation multiples can help compare stocks and provide ways for investors to identify value. But there can be a danger in focusing on them too much; if you only invested in stocks that traded at low earnings multiples, you could miss out on fast-growing businesses with lots of long-term potential.</p>\n<p>That's why an argument could be made that growth stocks like <b>Amazon&nbsp;</b>(NASDAQ:AMZN) and&nbsp;<b>Intuitive Surgical&nbsp;</b>(NASDAQ:ISRG), which aren't cheap by any stretch, may still deliver good returns for investors who hang on to these investments long enough.</p>\n<p><img src=\"https://static.tigerbbs.com/fcafb631d9483f8b901e77700427fa10\" tg-width=\"700\" tg-height=\"467\" referrerpolicy=\"no-referrer\">Image source: Getty Images.</p>\n<h2>1. Intuitive Surgical</h2>\n<p>Healthcare stock Intuitive Surgical trades at a price-to-earnings ratio (or P/E) of 76. That's extremely high when you consider that the average holding in the <b>Health Care Select Sector SPDR Fund</b> trades at just 27 times its profits.&nbsp;Value investors may be tempted to skip over Intuitive Surgical given such a high valuation.</p>\n<p>But the robotic-assisted surgery company is still in its very early growth stages. Analysts from Market Research Future project that the surgical robotics market will grow at a compound annual growth rate of 17% until 2027. And by then, it will still be worth only $13.7 billion. Healthcare giant&nbsp;<b>Johnson &amp; Johnson&nbsp;</b>records more revenue in just a three-month period.</p>\n<p>Intuitive Surgical is a long-term play. It could take more than 10 years for this company to really take off and be anywhere near the top players in the healthcare industry. But it has been generating good numbers already. During the trailing 12 months, the company has reported earnings of $1.6 billion on sales of $5.2 billion for an impressive profit margin of more than 31%. That's far better than the 20% of revenue that Johnson &amp; Johnson has been banking as profit over the past year.</p>\n<p>Key to Intuitive Surgical's growth are its da Vinci systems, which help surgeons perform complex and delicate procedures, utilizing robotics. The pandemic has negatively impacted its business as hospitals have pushed off procedures. Yet for the quarter ended June 30, the company shipped 328 of its surgical systems -- an 84% increase from a year ago. And the number of da Vinci procedures was also up 68% from the prior-year period. That boosted Intuitive Surgical's revenue by 72% to $1.46 billion.</p>\n<p>Demand for the company's da Vinci systems looks to be strong, and that's why this could make for a promising growth stock to hold for many years to come.</p>\n<h2>2. Amazon</h2>\n<p>Online retail giant Amazon is never a cheap stock to own. Its P/E of 58 is a bit lower than it has been in previous years, but that's largely to do with the surge in consumer purchases during the pandemic -- which have given its profits a big boost. In the past, it wouldn't be uncommon for the stock to be trading at more than 100 times its earnings.</p>\n<p>In 2020, the company's net sales of $386 billion were more than double the $178 billion it reported just three years earlier. Doubling revenue for a company of Amazon's size is no small feat. What's even more impressive is that during that time, its bottom line skyrocketed from just $3 billion to more than $21 billion.</p>\n<p>And while Amazon has been diversifying its business to include its subscription-related products, Amazon Web Services, and the grocery business (through Whole Foods), the company's online stores and third-party seller services still make up more than 70% of its top line.</p>\n<p>The company's wide array of expertise and resources gives Amazon many ways it can enter new markets and segments. One of its most recent areas of interest has been healthcare. Last year, it launched Amazon Pharmacy, a delivery service to help customers stay on top of their prescriptions. There were also rumors earlier this year that the business would take it even a step further and launch physical pharmacies, potentially going up against retail pharmacy chains <b><a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> </b>and&nbsp;<b>CVS Health</b>.</p>\n<p>For a business that has $90 billion in cash and marketable securities on its books as of June 30, Amazon can entertain any growth opportunity it wants. Amazon's stock will always command a premium as its business is synonymous with innovation. Given its dominance in the online world and many growth opportunities still out there, it is another stock that could be worth just buying and holding onto for many years.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Expensive Stocks That Can Still Produce Great Returns in the Long Run</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Expensive Stocks That Can Still Produce Great Returns in the Long Run\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-25 09:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/24/2-expensive-stocks-that-can-still-produce-great-re/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Valuation multiples can help compare stocks and provide ways for investors to identify value. But there can be a danger in focusing on them too much; if you only invested in stocks that traded at low ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/24/2-expensive-stocks-that-can-still-produce-great-re/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ISRG":"直觉外科公司","AMZN":"亚马逊"},"source_url":"https://www.fool.com/investing/2021/09/24/2-expensive-stocks-that-can-still-produce-great-re/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169615117","content_text":"Valuation multiples can help compare stocks and provide ways for investors to identify value. But there can be a danger in focusing on them too much; if you only invested in stocks that traded at low earnings multiples, you could miss out on fast-growing businesses with lots of long-term potential.\nThat's why an argument could be made that growth stocks like Amazon (NASDAQ:AMZN) and Intuitive Surgical (NASDAQ:ISRG), which aren't cheap by any stretch, may still deliver good returns for investors who hang on to these investments long enough.\nImage source: Getty Images.\n1. Intuitive Surgical\nHealthcare stock Intuitive Surgical trades at a price-to-earnings ratio (or P/E) of 76. That's extremely high when you consider that the average holding in the Health Care Select Sector SPDR Fund trades at just 27 times its profits. Value investors may be tempted to skip over Intuitive Surgical given such a high valuation.\nBut the robotic-assisted surgery company is still in its very early growth stages. Analysts from Market Research Future project that the surgical robotics market will grow at a compound annual growth rate of 17% until 2027. And by then, it will still be worth only $13.7 billion. Healthcare giant Johnson & Johnson records more revenue in just a three-month period.\nIntuitive Surgical is a long-term play. It could take more than 10 years for this company to really take off and be anywhere near the top players in the healthcare industry. But it has been generating good numbers already. During the trailing 12 months, the company has reported earnings of $1.6 billion on sales of $5.2 billion for an impressive profit margin of more than 31%. That's far better than the 20% of revenue that Johnson & Johnson has been banking as profit over the past year.\nKey to Intuitive Surgical's growth are its da Vinci systems, which help surgeons perform complex and delicate procedures, utilizing robotics. The pandemic has negatively impacted its business as hospitals have pushed off procedures. Yet for the quarter ended June 30, the company shipped 328 of its surgical systems -- an 84% increase from a year ago. And the number of da Vinci procedures was also up 68% from the prior-year period. That boosted Intuitive Surgical's revenue by 72% to $1.46 billion.\nDemand for the company's da Vinci systems looks to be strong, and that's why this could make for a promising growth stock to hold for many years to come.\n2. Amazon\nOnline retail giant Amazon is never a cheap stock to own. Its P/E of 58 is a bit lower than it has been in previous years, but that's largely to do with the surge in consumer purchases during the pandemic -- which have given its profits a big boost. In the past, it wouldn't be uncommon for the stock to be trading at more than 100 times its earnings.\nIn 2020, the company's net sales of $386 billion were more than double the $178 billion it reported just three years earlier. Doubling revenue for a company of Amazon's size is no small feat. What's even more impressive is that during that time, its bottom line skyrocketed from just $3 billion to more than $21 billion.\nAnd while Amazon has been diversifying its business to include its subscription-related products, Amazon Web Services, and the grocery business (through Whole Foods), the company's online stores and third-party seller services still make up more than 70% of its top line.\nThe company's wide array of expertise and resources gives Amazon many ways it can enter new markets and segments. One of its most recent areas of interest has been healthcare. Last year, it launched Amazon Pharmacy, a delivery service to help customers stay on top of their prescriptions. There were also rumors earlier this year that the business would take it even a step further and launch physical pharmacies, potentially going up against retail pharmacy chains Walgreens Boots Alliance and CVS Health.\nFor a business that has $90 billion in cash and marketable securities on its books as of June 30, Amazon can entertain any growth opportunity it wants. Amazon's stock will always command a premium as its business is synonymous with innovation. Given its dominance in the online world and many growth opportunities still out there, it is another stock that could be worth just buying and holding onto for many years.","news_type":1},"isVote":1,"tweetType":1,"viewCount":704,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860346204,"gmtCreate":1632141245308,"gmtModify":1632802590780,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Malaysia pandemic 🏳️","listText":"Malaysia pandemic 🏳️","text":"Malaysia pandemic 🏳️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/860346204","repostId":"2168502577","repostType":4,"repost":{"id":"2168502577","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1632128564,"share":"https://www.laohu8.com/m/news/2168502577?lang=&edition=full","pubTime":"2021-09-20 17:02","market":"sh","language":"en","title":"Li Auto Says Expects Its Vehicle Deliveries To Be About 24,500 Vehicles For Q3 Of 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2168502577","media":"Reuters","summary":"Sept 20 (Reuters) - Li Auto Inc. Updates Third Quarter Delivery Outlook.\nLi Auto- Due To Covid-19 Pa","content":"<p>Sept 20 (Reuters) - Li Auto Inc. Updates Third Quarter Delivery Outlook.</p>\n<p>Li Auto- Due To Covid-19 Pandemic In Malaysia, Production Of Chips Dedicated For Company'S Millimeter-Wave Radar Supplier Has Been Severely Hampered.</p>\n<p>Li Auto- As Recovery Of Chip Supply Has Been Slower Than Expected, Now Expects Its Vehicle Deliveries To Be About 24,500 Vehicles For Q3 Of 2021</p>\n<p>Li Auto fell over 3% in premarket trading.&nbsp;Other&nbsp;EV&nbsp;stocks&nbsp;fell&nbsp; in premarket trading&nbsp;too.</p>\n<p><img src=\"https://static.tigerbbs.com/addd9705b046e4446cbc1a29f95119da\" tg-width=\"250\" tg-height=\"288\" referrerpolicy=\"no-referrer\"></p>\n<p>((Reuters.Briefs@thomsonreuters.com;))</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Li Auto Says Expects Its Vehicle Deliveries To Be About 24,500 Vehicles For Q3 Of 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLi Auto Says Expects Its Vehicle Deliveries To Be About 24,500 Vehicles For Q3 Of 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-09-20 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Sept 20 (Reuters) - Li Auto Inc. Updates Third Quarter Delivery Outlook.</p>\n<p>Li Auto- Due To Covid-19 Pandemic In Malaysia, Production Of Chips Dedicated For Company'S Millimeter-Wave Radar Supplier Has Been Severely Hampered.</p>\n<p>Li Auto- As Recovery Of Chip Supply Has Been Slower Than Expected, Now Expects Its Vehicle Deliveries To Be About 24,500 Vehicles For Q3 Of 2021</p>\n<p>Li Auto fell over 3% in premarket trading.&nbsp;Other&nbsp;EV&nbsp;stocks&nbsp;fell&nbsp; in premarket trading&nbsp;too.</p>\n<p><img src=\"https://static.tigerbbs.com/addd9705b046e4446cbc1a29f95119da\" tg-width=\"250\" tg-height=\"288\" referrerpolicy=\"no-referrer\"></p>\n<p>((Reuters.Briefs@thomsonreuters.com;))</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LI":"理想汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2168502577","content_text":"Sept 20 (Reuters) - Li Auto Inc. Updates Third Quarter Delivery Outlook.\nLi Auto- Due To Covid-19 Pandemic In Malaysia, Production Of Chips Dedicated For Company'S Millimeter-Wave Radar Supplier Has Been Severely Hampered.\nLi Auto- As Recovery Of Chip Supply Has Been Slower Than Expected, Now Expects Its Vehicle Deliveries To Be About 24,500 Vehicles For Q3 Of 2021\nLi Auto fell over 3% in premarket trading. Other EV stocks fell  in premarket trading too.\n\n((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":305,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887599912,"gmtCreate":1632058969336,"gmtModify":1632803091333,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Cheers towards financial freedom 💰","listText":"Cheers towards financial freedom 💰","text":"Cheers towards financial freedom 💰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/887599912","repostId":"1198486138","repostType":4,"repost":{"id":"1198486138","pubTimestamp":1632023224,"share":"https://www.laohu8.com/m/news/1198486138?lang=&edition=full","pubTime":"2021-09-19 11:47","market":"us","language":"en","title":"7 ways men live without working in America","url":"https://stock-news.laohu8.com/highlight/detail?id=1198486138","media":"Yahoo Finance","summary":"How do they live? What are they doing for money? ","content":"<p>Almost one-third of all working-age men in America aren’t doing diddly-squat. They don’t have a job, and they aren’t looking for one either. One-third of all working-age men. That’s almost 30 million people!</p>\n<p>How do they live? What are they doing for money? To me, this is one of the great mysteries of our time.</p>\n<p>I’m certainly not the first person to make note of this shocking statistic. You’ve heard people bemoaning this \"labor participation rate,\" which is simply the number of working-age men (usually counted as ages 16 to 64) not working or not looking for work, as a percentage of the overall labor force.</p>\n<p>It’s true that the pandemic, which of course produced a number of factors that made working more difficult never mind dangerous, pushed the labor participation rate to a record low. But the fact that millions of American males have not been working precedes COVID-19 by decades. In fact, the participation rate for men peaked at 87.4% in October 1949 and has been dropping steadily ever since. It now stands at 67.7%.</p>\n<p>As a business journalist for a good portion of those 70-plus years, I’ve looked at thousands of charts and graphs in my life, and I have to say this one is as jaw dropping as it is vexing:</p>\n<p><img src=\"https://static.tigerbbs.com/056158b8fa7157238c3d1521dd05c02e\" tg-width=\"705\" tg-height=\"259\" referrerpolicy=\"no-referrer\">Chart of the U.S. labor force participation rate for men over time, courtesy of the St. Louis Federal Reserve</p>\n<p>Economists, sociologists, politicians, and cable news pundits each have their pet factors to explain the groundswell of non-work. But after digging down here, I’ve concluded there are many different forces at play. That’s what I want to explore today, which is: how men can live in America without working.</p>\n<p>I’m not talking about why men have lost their jobs — factories closing, layoffs, automation, outsourcing jobs overseas, even perhaps women entering the workforce, (in fact, the participation rate by women over the same time period is way up). What I want to get at is how they’re living without holding a \"real\" job, and by that I mean doing work where one reports income to the IRS, pays taxes and Social Security, etc.</p>\n<p>It’s important to note that every man in this group has his own story. They range from mentally ill homeless men who desperately need our help, to the I’m-doing-just-fine-thank-you-very-much, retired early, and former Silicon Valley coder. And there are infinite scenarios in between those two extremes, including, for instance, the many men who have chosen to bestay-at-home dadswhile their spouses work.</p>\n<p>It’s also the case that some men in this group may be unemployed and not seeking work because they’ve given up looking just for now — perhaps waiting for COVID to abate — and will start the search again soon. Here too, society needs to help.</p>\n<p>Still, none of this explains decade after decade of falling male employment.</p>\n<p>To that end, here to my mind are seven ways men are living without working in America:</p>\n<p><b>-Unemployment insurance</b></p>\n<p>Let’s start with this one because it’s a hot button issue. Conservatives and some liberals too have made the claim that state unemployment aid, coupled with $600 a week from the CARES Act, which was rolled out in March 2020, have reduced men’s need to work. (There are actually a variety of social programs at play,spelled out nicely hereby think tank The Century Foundation, which estimates that overall these programs have pumped $800 billion in the economy.) We’ll be getting a good read on whether all this relief did suppress employment now that CARES aid ended for some 7.5 million Americans earlier this month. But as Yahoo Finance’s Denitsa Tsekova reportedhereandhere, states that ended federal aid programs early didn’t see big increases in employment. That may mean these payments really weren’t enough to live off, or not enough to live off by themselves, which speaks to men looking to a combination of sources, like under the table income or family support and possibly some savings (see below).</p>\n<p><b>-Early retirement, pensions, disability and lawsuits</b></p>\n<p>Admittedly, this is a bit of a hodgepodge. And as is the case with many of these categories, hard data is tough to come by, but it is the case that millions of men under 64 are at least partly living off of pensions and 401(k)s. This would include everything from C-suite executives to union members. And don’t forget municipal workers, who make up almost 14% of the U.S. workforce. According to the U.S. Census Bureau, there are some 6,000 public sector retirement systems in the U.S.Collectively these plans have $4.5 trillion in assets,with 14.7 million working members and 11.2 million retirees. The plans distribute $323 billion in benefits annually, and again, some to men who are younger than 64. In fact in almost two-thirds of these plans,if you started working at 25, you max out at 57, a real inducement to stop working — at least at that job of course.</p>\n<p><img src=\"https://static.tigerbbs.com/53e26b293f8a939a54b78315c3375a18\" tg-width=\"705\" tg-height=\"467\" referrerpolicy=\"no-referrer\">Volunteers load cars with turkeys and other food assistance for laid off Walt Disney World cast members and others at a food distribution event on December 12, 2020 in Orlando, Florida. (Photo by Paul Hennessy/NurPhoto via Getty Images)More</p>\n<p>There’s also disability insurance from the Social Security Administration that is beingpaid to some 9 million Americanswhomay receive payments many years before retirement age. That's why I am including disability here, but not plain vanilla Social Security, which you can’t receive until age 62. The maximum disability benefit amount you can receive each month is currently $3,148. (However, the average beneficiary receives about $1,277 per month, according to the law group Social Security Disability Advocates.) Overall, it looks like theSSA pays out some $130 billion in disability annually.That’s not nothing. Then there’s money paid out in medical malpractice each year, smaller true, but stillestimated to be in excess of $3 billion.And don't forgetpayments from legal settlements and class action lawsuits.</p>\n<p>You argue all day about the right or wrong when it comes to these payouts, but the fact is many of them didn’t exist, or not at this magnitude, decades ago.</p>\n<p><b>-Savings, trading stocks, and bitcoin</b></p>\n<p>Consider now men are living off savings, or from money made in the market or maybe even selling NFTs. How many is it exactly? Who knows, but quite a few for sure. First off, Americans on average do have some money in the bank. Savings as a percentage of disposable income,according to the Federal Reserve of Kansas City,hit a record high of 33% in the spring of 2020 and is still at 14%, or nearly twice as high as it was prior to the pandemic.</p>\n<p>And according to arecent survey by Northwestern Mutual,average personal savings are up over 10% compared to last year, from $65,900 last year to $73,100. Average retirement savings increased 13%, from $87,500 last year to $98,800 today. So there’s that.</p>\n<p>Next let’s look at investing — first stocks. It is not irrelevant to this narrative that the S&amp;P 500 has climbed from 2,480 on March 12, 2020 — the day after the World Health Organization declared COVID a pandemic— to 4,441 today, or almost 80%. That’s a huge gain. Much of the action of course has been retail investors and the meme stock boom, as millions of American males stuck at home with nothing to do all day for the past 18 months passed the time trading stocks. Credit Suisse estimates that since the beginning of 2020, “retail trading as a share of overall market activityhas nearly doubledfrom between 15% and 18% to over 30%,” as CNBC reported. How many men were doing this and supporting themselves? Unclear, but upstart trading platform Robinhood (HOOD) — the broker dealer of choice for many of these new investors — reported that it had22.5 million funded user accountslast month, up from 7.2 million in March of 2020. Let’s just say 15 million new accounts is quite a number.</p>\n<p>Now crypto. You can laugh all you want, but the simple fact is that theprice of bitcoinis up from $4,861 on March 12, 2000 to $47,763 today, or basically up 10X, (and remember it even hit $64,888.99 this spring). Back to Robinhood, which according to The New York Times, also reported last month that “revenue from cryptocurrency trading fees totaled $233 million, a nearly 50-fold jump from $5 million a year earlier.” (And those are just fees off the trades, mind you.) Bottom line: Folks have made money here. (Of course these guys should be paying taxes on all those stock and crypto gains.)</p>\n<p><img src=\"https://static.tigerbbs.com/809084435ffdcbc0695311d158bb7a98\" tg-width=\"705\" tg-height=\"470\" referrerpolicy=\"no-referrer\">Robinhood Markets, Inc. CEO and co-founder Vlad Tenev and co-founder Baiju Bhatt pose with Robinhood signage on Wall Street after the company's IPO in New York City, U.S., July 29, 2021. REUTERS/Andrew Kelly<b>-Working for cash, aka the under-the-table economy</b></p>\n<p>This one is very tough to measure, too.A study by the Federal Reserve of St. Louisestimates that the average size of the “informal economy” in developed countries is 13% of GDP. Honestly, that could be off by many percentage points, but just to give you a ballpark, GDP in the U.S. this year is about $22 trillion. So 13% of that is $2.86 trillion. As it turns out, $2 trillion-plus, is a number that has been thrown around quite a bit (hereandherefor instance) when it comes to estimating the size of the cash economy in the U.S. Even if half that money is paid out to women, that still leaves, say, $1 trillion dollars being made by men in this country off the books. That’s a big chunk of change. Are more people than ever working for cash these days? Again, another question that’s impossible to answer. I would bet it’s not fewer. For example, my electrician Luis just told me he can’t get anyone to work for him anymore — they all want to get paid in cash.</p>\n<p><b>-Living off family members</b></p>\n<p>Just to take one facet,the Pew Research Center reportedlast year that the pandemic “has pushed millions of Americans, especially young adults, to move in with family members. The share of 18- to 29-year-olds living with their parents has become a majority since U.S. coronavirus cases began spreading [in early 2020], surpassing the previous peak during the Great Depression era. In July, 52% of young adults resided with one or both of their parents, up from 47% in February.” How many of these individuals are males living rent free (and sharing food too), which maybe means they don’t have to work? Who knows, but some. Ditto for males who have moved in with in-laws or siblings. And again, many men are choosing to stay home and take care of kids while their spouses work.</p>\n<p><b>-Illegal work</b></p>\n<p>Front and center here is selling illegal drugs. Sadly, business looks to be booming, that is if overdoses are any sort of measure.According to the Washington Post, overdose deaths hit 93,000 last year, up a stunning 30% from 2019. Most of the overdoses were attributed to opioids; heroin, synthetic opioids like OxyContin and in particular Fentanyl. (This despite drug dealers facingsupply chain issuesduring COVID.) How many Americans are in this business and who are they? A number is almost impossible to come by here, but as for who they are,a government report on drug trafficking arrestsfrom five years ago notes that ”the majority of drug trafficking offenders were male (84.9%), the average age of these offenders at sentencing was 36 years, 70% were United States citizens (although this rate varied substantially depending on the type of drug involved), and that almost half (49.4%) of drug traffickers had little or no prior criminal history.” How big a business is selling drugs in America? Could beas much as $100 billion.I think it’s fair to say that a market that size requires many thousands of employees.</p>\n<p>What about other types of crime and criminals, everything from robbers and thieves to prostitutes and pimps? To that point there aresome 2 million people incarcerated in the U.S.right now. (We have the highest absolute number and the highest per capita on the planet, and holdsome 25% of the world's total prisoners, according to the ACLU.) Being in prison is another way of living in America without working, I guess. But not counting those locked up, how many bad guys are out there on the street? Conservatively, it has to be thousands and thousands, and speaking to this story, they're all doing their thing and not participating in the labor force.</p>\n<p><img src=\"https://static.tigerbbs.com/3f8f4b3e6a5aa97a10f5c7bb22dec1d7\" tg-width=\"705\" tg-height=\"470\" referrerpolicy=\"no-referrer\">ORLEANS, MASSACHUSETTS - JULY 10: A man holds onto a clamming rake while clamming at low tide July 10, 2021 in Town Cove, Orleans, Massachusetts. He filled a bushel basket of cherry stone clams. (Photo by Robert Nickelsberg/Getty Images)More<b>-Living off the land</b></p>\n<p>This would include gardening, fishing, hunting, clamming, berrying, and just general foraging. The numbers here seem to be climbing. Here for instancefrom The Guardian:</p>\n<p>“Fishing and huntinglicense sales increased 10%in California during the pandemic, reversing years of decline. Clamming has grown in popularity for several reasons: people are looking for safe activities to do outdoors, but also some are clamming for subsistence and trying to get money from selling the shellfish (which is illegal without a commercial license).”</p>\n<p>Ditto for Washington state, according to The Spokesman-Review:</p>\n<p>“From the start of the 2020 licensing year in May through Dec. 31, WDFW [Washington Department of Fish and Wildlife] sold nearly 45,000 more fishing licenses and 12,000 more hunting licenses than 2019. The number of new license holders — defined as someone who hadn’t purchased one for the previous five years — went up 16% for fishing licenses and almost 40% for hunters.”</p>\n<p>As for growing vegetables in home gardens, yes, it is up, way up too. Even before the pandemic, there were estimates thata third of American families grew vegetables.Now this,NPRreported last year:</p>\n<p>“‘We're being flooded with vegetable orders,’ says George Ball, executive chairman of the Burpee Seed Company, based in Warminster, Penn.</p>\n<p>Ball says he has noticed spikes in seed sales during bad times: the stock market crash of 1987, the dot com bubble burst of 2000, and he remembers the two oil crises of the 1970s from his childhood. But he says he has not seen a spike this large and widespread.</p>\n<p>So there you have it. It’s a whole range of ways and means, behaviors and experiences. I’m sure I missed some, too. Again, some non-working men are in dire straits and need our help. Others are living non-working lives without burdening society or others, such as a fireman on early retirement (though some argue municipal employee pensions are too high), or an investor who made a ton of money in the market and called it quits, or maybe a wilderness guy living off the land in Alaska.</p>\n<p>And some non-working men are not playing fair. Like getting paid under the table, fudging insurance claims or social programs. Some freeload off relatives. And some engage in overtly illegal behavior like boosting branded goods from chain stores to sell online or dealing heroin.</p>\n<p>I would imagine that more than a few of these men create a portfolio of sources, though I’m not sure they really think of it that way. Take for example a hypothetical guy in a rural area who lives with his grandmother rent free, (he does help her with the garden some). This guy also does some cash carpentry work, hunts for game, gets some food off his ex-wife’s WIC and helps his brother sell some weed. Can you get by this way? Some men probably are. Is this the new American way? For some men it probably is.</p>\n<p>That example perhaps, and to be sure of all of the above, I think go a long way toward explaining that chart from the beginning of the story, the one that shows the labor participation rate falling off a cliff over the past seven decades. And speaking of charts, another striking one came to mind when I was writing this, which I put here below. It shows U.S. GDP over the same time period as the labor participation rate.</p>\n<p><img src=\"https://static.tigerbbs.com/0f197be5c6c11483ec906a1757293e4d\" tg-width=\"705\" tg-height=\"259\" referrerpolicy=\"no-referrer\">Chart of the U.S. Gross Domestic Product over time, courtesy of the St. Louis Federal Reserve</p>\n<p>Of course, the line on this GDP chart is inversely correlated with the line on the labor participation graph. And I think there is a relationship between the two. Which is to say, the wealthier our nation has become over the decades, the less men are working. Fact is there is just a ton of money sloshing around in our country. And men seem to be able to get their hands on it, whether obtained legally, borrowed, leached off of or stolen.</p>\n<p>It seems like working legally to provide for yourself in America is really just one option these days.</p>\n<p><b><i>This article was featured in a Saturday edition of the Morning Brief on September 18, 2021. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET.Subscribe</i></b></p>\n<p><i>Andy Serwer is editor-in-chief of Yahoo Finance. Follow him on Twitter:@serwer</i></p>","source":"yahoofinance_sg","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>7 ways men live without working in America</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n7 ways men live without working in America\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-19 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/7-ways-men-live-without-working-in-america-092147068.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Almost one-third of all working-age men in America aren’t doing diddly-squat. They don’t have a job, and they aren’t looking for one either. One-third of all working-age men. That’s almost 30 million ...</p>\n\n<a href=\"https://finance.yahoo.com/news/7-ways-men-live-without-working-in-america-092147068.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/020219c8820f9fc9f11979454ce1b1c6","relate_stocks":{".DJI":"道琼斯"},"source_url":"https://finance.yahoo.com/news/7-ways-men-live-without-working-in-america-092147068.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1198486138","content_text":"Almost one-third of all working-age men in America aren’t doing diddly-squat. They don’t have a job, and they aren’t looking for one either. One-third of all working-age men. That’s almost 30 million people!\nHow do they live? What are they doing for money? To me, this is one of the great mysteries of our time.\nI’m certainly not the first person to make note of this shocking statistic. You’ve heard people bemoaning this \"labor participation rate,\" which is simply the number of working-age men (usually counted as ages 16 to 64) not working or not looking for work, as a percentage of the overall labor force.\nIt’s true that the pandemic, which of course produced a number of factors that made working more difficult never mind dangerous, pushed the labor participation rate to a record low. But the fact that millions of American males have not been working precedes COVID-19 by decades. In fact, the participation rate for men peaked at 87.4% in October 1949 and has been dropping steadily ever since. It now stands at 67.7%.\nAs a business journalist for a good portion of those 70-plus years, I’ve looked at thousands of charts and graphs in my life, and I have to say this one is as jaw dropping as it is vexing:\nChart of the U.S. labor force participation rate for men over time, courtesy of the St. Louis Federal Reserve\nEconomists, sociologists, politicians, and cable news pundits each have their pet factors to explain the groundswell of non-work. But after digging down here, I’ve concluded there are many different forces at play. That’s what I want to explore today, which is: how men can live in America without working.\nI’m not talking about why men have lost their jobs — factories closing, layoffs, automation, outsourcing jobs overseas, even perhaps women entering the workforce, (in fact, the participation rate by women over the same time period is way up). What I want to get at is how they’re living without holding a \"real\" job, and by that I mean doing work where one reports income to the IRS, pays taxes and Social Security, etc.\nIt’s important to note that every man in this group has his own story. They range from mentally ill homeless men who desperately need our help, to the I’m-doing-just-fine-thank-you-very-much, retired early, and former Silicon Valley coder. And there are infinite scenarios in between those two extremes, including, for instance, the many men who have chosen to bestay-at-home dadswhile their spouses work.\nIt’s also the case that some men in this group may be unemployed and not seeking work because they’ve given up looking just for now — perhaps waiting for COVID to abate — and will start the search again soon. Here too, society needs to help.\nStill, none of this explains decade after decade of falling male employment.\nTo that end, here to my mind are seven ways men are living without working in America:\n-Unemployment insurance\nLet’s start with this one because it’s a hot button issue. Conservatives and some liberals too have made the claim that state unemployment aid, coupled with $600 a week from the CARES Act, which was rolled out in March 2020, have reduced men’s need to work. (There are actually a variety of social programs at play,spelled out nicely hereby think tank The Century Foundation, which estimates that overall these programs have pumped $800 billion in the economy.) We’ll be getting a good read on whether all this relief did suppress employment now that CARES aid ended for some 7.5 million Americans earlier this month. But as Yahoo Finance’s Denitsa Tsekova reportedhereandhere, states that ended federal aid programs early didn’t see big increases in employment. That may mean these payments really weren’t enough to live off, or not enough to live off by themselves, which speaks to men looking to a combination of sources, like under the table income or family support and possibly some savings (see below).\n-Early retirement, pensions, disability and lawsuits\nAdmittedly, this is a bit of a hodgepodge. And as is the case with many of these categories, hard data is tough to come by, but it is the case that millions of men under 64 are at least partly living off of pensions and 401(k)s. This would include everything from C-suite executives to union members. And don’t forget municipal workers, who make up almost 14% of the U.S. workforce. According to the U.S. Census Bureau, there are some 6,000 public sector retirement systems in the U.S.Collectively these plans have $4.5 trillion in assets,with 14.7 million working members and 11.2 million retirees. The plans distribute $323 billion in benefits annually, and again, some to men who are younger than 64. In fact in almost two-thirds of these plans,if you started working at 25, you max out at 57, a real inducement to stop working — at least at that job of course.\nVolunteers load cars with turkeys and other food assistance for laid off Walt Disney World cast members and others at a food distribution event on December 12, 2020 in Orlando, Florida. (Photo by Paul Hennessy/NurPhoto via Getty Images)More\nThere’s also disability insurance from the Social Security Administration that is beingpaid to some 9 million Americanswhomay receive payments many years before retirement age. That's why I am including disability here, but not plain vanilla Social Security, which you can’t receive until age 62. The maximum disability benefit amount you can receive each month is currently $3,148. (However, the average beneficiary receives about $1,277 per month, according to the law group Social Security Disability Advocates.) Overall, it looks like theSSA pays out some $130 billion in disability annually.That’s not nothing. Then there’s money paid out in medical malpractice each year, smaller true, but stillestimated to be in excess of $3 billion.And don't forgetpayments from legal settlements and class action lawsuits.\nYou argue all day about the right or wrong when it comes to these payouts, but the fact is many of them didn’t exist, or not at this magnitude, decades ago.\n-Savings, trading stocks, and bitcoin\nConsider now men are living off savings, or from money made in the market or maybe even selling NFTs. How many is it exactly? Who knows, but quite a few for sure. First off, Americans on average do have some money in the bank. Savings as a percentage of disposable income,according to the Federal Reserve of Kansas City,hit a record high of 33% in the spring of 2020 and is still at 14%, or nearly twice as high as it was prior to the pandemic.\nAnd according to arecent survey by Northwestern Mutual,average personal savings are up over 10% compared to last year, from $65,900 last year to $73,100. Average retirement savings increased 13%, from $87,500 last year to $98,800 today. So there’s that.\nNext let’s look at investing — first stocks. It is not irrelevant to this narrative that the S&P 500 has climbed from 2,480 on March 12, 2020 — the day after the World Health Organization declared COVID a pandemic— to 4,441 today, or almost 80%. That’s a huge gain. Much of the action of course has been retail investors and the meme stock boom, as millions of American males stuck at home with nothing to do all day for the past 18 months passed the time trading stocks. Credit Suisse estimates that since the beginning of 2020, “retail trading as a share of overall market activityhas nearly doubledfrom between 15% and 18% to over 30%,” as CNBC reported. How many men were doing this and supporting themselves? Unclear, but upstart trading platform Robinhood (HOOD) — the broker dealer of choice for many of these new investors — reported that it had22.5 million funded user accountslast month, up from 7.2 million in March of 2020. Let’s just say 15 million new accounts is quite a number.\nNow crypto. You can laugh all you want, but the simple fact is that theprice of bitcoinis up from $4,861 on March 12, 2000 to $47,763 today, or basically up 10X, (and remember it even hit $64,888.99 this spring). Back to Robinhood, which according to The New York Times, also reported last month that “revenue from cryptocurrency trading fees totaled $233 million, a nearly 50-fold jump from $5 million a year earlier.” (And those are just fees off the trades, mind you.) Bottom line: Folks have made money here. (Of course these guys should be paying taxes on all those stock and crypto gains.)\nRobinhood Markets, Inc. CEO and co-founder Vlad Tenev and co-founder Baiju Bhatt pose with Robinhood signage on Wall Street after the company's IPO in New York City, U.S., July 29, 2021. REUTERS/Andrew Kelly-Working for cash, aka the under-the-table economy\nThis one is very tough to measure, too.A study by the Federal Reserve of St. Louisestimates that the average size of the “informal economy” in developed countries is 13% of GDP. Honestly, that could be off by many percentage points, but just to give you a ballpark, GDP in the U.S. this year is about $22 trillion. So 13% of that is $2.86 trillion. As it turns out, $2 trillion-plus, is a number that has been thrown around quite a bit (hereandherefor instance) when it comes to estimating the size of the cash economy in the U.S. Even if half that money is paid out to women, that still leaves, say, $1 trillion dollars being made by men in this country off the books. That’s a big chunk of change. Are more people than ever working for cash these days? Again, another question that’s impossible to answer. I would bet it’s not fewer. For example, my electrician Luis just told me he can’t get anyone to work for him anymore — they all want to get paid in cash.\n-Living off family members\nJust to take one facet,the Pew Research Center reportedlast year that the pandemic “has pushed millions of Americans, especially young adults, to move in with family members. The share of 18- to 29-year-olds living with their parents has become a majority since U.S. coronavirus cases began spreading [in early 2020], surpassing the previous peak during the Great Depression era. In July, 52% of young adults resided with one or both of their parents, up from 47% in February.” How many of these individuals are males living rent free (and sharing food too), which maybe means they don’t have to work? Who knows, but some. Ditto for males who have moved in with in-laws or siblings. And again, many men are choosing to stay home and take care of kids while their spouses work.\n-Illegal work\nFront and center here is selling illegal drugs. Sadly, business looks to be booming, that is if overdoses are any sort of measure.According to the Washington Post, overdose deaths hit 93,000 last year, up a stunning 30% from 2019. Most of the overdoses were attributed to opioids; heroin, synthetic opioids like OxyContin and in particular Fentanyl. (This despite drug dealers facingsupply chain issuesduring COVID.) How many Americans are in this business and who are they? A number is almost impossible to come by here, but as for who they are,a government report on drug trafficking arrestsfrom five years ago notes that ”the majority of drug trafficking offenders were male (84.9%), the average age of these offenders at sentencing was 36 years, 70% were United States citizens (although this rate varied substantially depending on the type of drug involved), and that almost half (49.4%) of drug traffickers had little or no prior criminal history.” How big a business is selling drugs in America? Could beas much as $100 billion.I think it’s fair to say that a market that size requires many thousands of employees.\nWhat about other types of crime and criminals, everything from robbers and thieves to prostitutes and pimps? To that point there aresome 2 million people incarcerated in the U.S.right now. (We have the highest absolute number and the highest per capita on the planet, and holdsome 25% of the world's total prisoners, according to the ACLU.) Being in prison is another way of living in America without working, I guess. But not counting those locked up, how many bad guys are out there on the street? Conservatively, it has to be thousands and thousands, and speaking to this story, they're all doing their thing and not participating in the labor force.\nORLEANS, MASSACHUSETTS - JULY 10: A man holds onto a clamming rake while clamming at low tide July 10, 2021 in Town Cove, Orleans, Massachusetts. He filled a bushel basket of cherry stone clams. (Photo by Robert Nickelsberg/Getty Images)More-Living off the land\nThis would include gardening, fishing, hunting, clamming, berrying, and just general foraging. The numbers here seem to be climbing. Here for instancefrom The Guardian:\n“Fishing and huntinglicense sales increased 10%in California during the pandemic, reversing years of decline. Clamming has grown in popularity for several reasons: people are looking for safe activities to do outdoors, but also some are clamming for subsistence and trying to get money from selling the shellfish (which is illegal without a commercial license).”\nDitto for Washington state, according to The Spokesman-Review:\n“From the start of the 2020 licensing year in May through Dec. 31, WDFW [Washington Department of Fish and Wildlife] sold nearly 45,000 more fishing licenses and 12,000 more hunting licenses than 2019. The number of new license holders — defined as someone who hadn’t purchased one for the previous five years — went up 16% for fishing licenses and almost 40% for hunters.”\nAs for growing vegetables in home gardens, yes, it is up, way up too. Even before the pandemic, there were estimates thata third of American families grew vegetables.Now this,NPRreported last year:\n“‘We're being flooded with vegetable orders,’ says George Ball, executive chairman of the Burpee Seed Company, based in Warminster, Penn.\nBall says he has noticed spikes in seed sales during bad times: the stock market crash of 1987, the dot com bubble burst of 2000, and he remembers the two oil crises of the 1970s from his childhood. But he says he has not seen a spike this large and widespread.\nSo there you have it. It’s a whole range of ways and means, behaviors and experiences. I’m sure I missed some, too. Again, some non-working men are in dire straits and need our help. Others are living non-working lives without burdening society or others, such as a fireman on early retirement (though some argue municipal employee pensions are too high), or an investor who made a ton of money in the market and called it quits, or maybe a wilderness guy living off the land in Alaska.\nAnd some non-working men are not playing fair. Like getting paid under the table, fudging insurance claims or social programs. Some freeload off relatives. And some engage in overtly illegal behavior like boosting branded goods from chain stores to sell online or dealing heroin.\nI would imagine that more than a few of these men create a portfolio of sources, though I’m not sure they really think of it that way. Take for example a hypothetical guy in a rural area who lives with his grandmother rent free, (he does help her with the garden some). This guy also does some cash carpentry work, hunts for game, gets some food off his ex-wife’s WIC and helps his brother sell some weed. Can you get by this way? Some men probably are. Is this the new American way? For some men it probably is.\nThat example perhaps, and to be sure of all of the above, I think go a long way toward explaining that chart from the beginning of the story, the one that shows the labor participation rate falling off a cliff over the past seven decades. And speaking of charts, another striking one came to mind when I was writing this, which I put here below. It shows U.S. GDP over the same time period as the labor participation rate.\nChart of the U.S. Gross Domestic Product over time, courtesy of the St. Louis Federal Reserve\nOf course, the line on this GDP chart is inversely correlated with the line on the labor participation graph. And I think there is a relationship between the two. Which is to say, the wealthier our nation has become over the decades, the less men are working. Fact is there is just a ton of money sloshing around in our country. And men seem to be able to get their hands on it, whether obtained legally, borrowed, leached off of or stolen.\nIt seems like working legally to provide for yourself in America is really just one option these days.\nThis article was featured in a Saturday edition of the Morning Brief on September 18, 2021. Get the Morning Brief sent directly to your inbox every Monday to Friday by 6:30 a.m. ET.Subscribe\nAndy Serwer is editor-in-chief of Yahoo Finance. Follow him on Twitter:@serwer","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":862879045,"gmtCreate":1632872589466,"gmtModify":1632872589466,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Appreciate the insight. I have&nbsp;added some of them to my&nbsp;watchlist. I think it’s really helpful for people like me who has small capital. 🍻","listText":"Appreciate the insight. I have&nbsp;added some of them to my&nbsp;watchlist. I think it’s really helpful for people like me who has small capital. 🍻","text":"Appreciate the insight. I have added some of them to my watchlist. I think it’s really helpful for people like me who has small capital. 🍻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/862879045","repostId":"2170672462","repostType":4,"repost":{"id":"2170672462","pubTimestamp":1632835246,"share":"https://www.laohu8.com/m/news/2170672462?lang=&edition=full","pubTime":"2021-09-28 21:20","market":"us","language":"en","title":"Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=2170672462","media":"Motley Fool","summary":"Bargains can still be found, even with the broader market near an all-time high.","content":"<p>If investors thought the coronavirus crash was historic, the bounce-back rally from the March 2020 bottom has been even more impressive. The benchmark <b>S&amp;P 500</b> took less than 17 months to double from its lows, and it's now gone 10 months without so much as a 5% downside correction. Patience is truly paying off for long-term investors.</p>\n<p>But just because the broader market is a stone's throw from a record high doesn't mean investors can't still find bargains. If you've got $1,000 ready to invest, which won't be needed for bill or emergencies, the following five stocks would make for perfect buys for the fourth quarter.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8cf8fd6cbc9120f885acecdfb00d5835\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Novavax</h2>\n<p>While I'm generally not a fan of chasing the coronavirus stocks after they've catapulted into the stratosphere, clinical-stage biotech stock <b>Novavax</b> (NASDAQ:NVAX) is the rare exception. It's unlikely to remain a clinical-stage company for much longer and could offer clear advantages that'll help it become a top vaccine player.</p>\n<p>The company's coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373, led to an 89.7% vaccine efficacy (VE) in a large-scale trial in the U.K. earlier this year, and it produced a nearly identical 90.4% VE in a large-scale trial in the U.S. and Mexico in June. This initial efficacy, coupled with the less-than-stellar uptake from <b>AstraZeneca</b>'s and <b>Johnson &amp; Johnson</b>'s COVID-19 vaccines, should open the door for Novavax to become the No. 3 player in developed markets.</p>\n<p>Also working in Novavax's favor is the mutability of the SARS-CoV-2 virus that causes COVID-19. Novavax's drug-development platform is capable of quickly bringing variant-specific vaccines to trial, if necessary. The company could also benefit from the need for booster shots, depending on how long vaccine-based immunity lasts.</p>\n<p>Novavax has an opportunity to beat its peers to market with a combination COVID-19/influenza vaccine, as well. This could be a differentiating vaccine that really allows the company to stand out.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/31d9e4dd60375f8f383f0c222a7633a4\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Exelixis</h2>\n<p>Biotech stocks are a common theme on this list of perfect stocks to buy for the fourth quarter. Cancer drug developer <b>Exelixis</b> (NASDAQ:EXEL) offers the right blend of growth and value to make patient investors richer.</p>\n<p>The superstar for Exelixis continues to be cancer drug Cabometyx, which derives the bulk of its sales from its first-and-second-line approvals in renal cell carcinoma (RCC) and its approval to treat advanced hepatocellular carcinoma. These indications should help Cabometyx top $1 billion in recurring sales either this year or 2022.</p>\n<p>The only reason this company is as inexpensive as it is now -- 21 times forward-year earnings for sustainable mid-teens sales growth -- is the disappointing update from the Cosmic-312 trial. Though the combination of Cabometyx and atezolizumab led to a statistically significant improvement in progression-free survival for previously untreated liver cancer patients, Exelixis notes that it's unlikely to demonstrate a statistically significant improvement in overall survival by trial completion in early 2022.</p>\n<p>While this might sound like a disappointment, it isn't. It's par for the course when developing blockbuster cancer drugs. Cabometyx failed in a late-stage study targeted at prostate cancer patients in 2014 but has since bounced back to gain numerous approvals. With this key drug being examined in close to six dozen clinical trials, label expansion opportunities remain abundant for Exelixis.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e5596b9cd58d43ee65824bd7892b9c5e\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Broadcom</h2>\n<p>Stepping outside the healthcare arena for the moment, semiconductor solutions provider <b>Broadcom</b> (NASDAQ:AVGO) is a perfect stock to put $1,000 to work in for the fourth quarter. I say \"perfect,\" because Broadcom is at the center of two very sustainable growth trends.</p>\n<p>First, it's going to be a multiyear beneficiary of the rollout of 5G wireless infrastructure. A majority of Broadcom's revenue comes from wireless chips and other accessories found in smartphones. Because it's been a decade since consumers and businesses have benefited from an upgrade to wireless download speeds, the expectation is that we'll see a sustainable, multiyear device replacement cycle. This should allow Broadcom to lock in its orders months or years in advance.</p>\n<p>But it's not just smartphones that should have investors excited about Broadcom. The pandemic has also accelerated the shift of enterprise and consumer data into the cloud. This means data center demand should be strong for a long time to come. Broadcom is a provider of connectivity and access chips used by enterprise data centers.</p>\n<p>The icing on the cake here is that the company has grown its quarterly dividend by more than 5,000% in less than 11 years. Investors can collect a nearly 3% yield as they sit back and watch Broadcom's profitability climb.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2fc0013108c05865a77a8fa2e9b54b23\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Vertex Pharmaceuticals</h2>\n<p>Similar to Exelixis, specialty biotech stock <b>Vertex Pharmaceuticals</b> (NASDAQ:VRTX) offers the right blend of double-digit sales growth and insane value (a forward-year price-to-earnings ratio of only 14), which makes it a no-brainer buy for the fourth quarter.</p>\n<p>What allows Vertex to stand out is its overwhelming success in developing multiple generations of treatments for patients with cystic fibrosis (CF). CF is a genetic disease characterized by thick mucus production that can obstruct the pancreas and/or lungs. Vertex's latest treatment, combination therapy Trikafta, was approved five months ahead of the U.S. Food and Drug Administration's review date, and is pacing $5 billion in annual run-rate sales despite hitting pharmacy shelves less than two years ago.</p>\n<p>Keeping with the similarities to Exelixis, Vertex was hit hard twice over the past year after two separate experimental treatments targeting alpha-1 antitrypsin deficiency were discontinued in mid-stage trials. Nevertheless, Vertex has more than a half-dozen combined internal and out-licensed treatments in development for a variety of indications. Even though its CF franchise is well-protected from competition, the company is working on an expansive pipeline of products.</p>\n<p>And don't overlook Vertex's cash pile. It ended June with about $6.7 billion in cash and cash equivalents, which is more than enough to fuel internal development, fund novel partnerships, or make acquisitions.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/39a1727edeb0317fbc6386d8981fd8e0\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"><span>Image source: Getty Images.</span></p>\n<h2>Teladoc Health</h2>\n<p>Lastly, buying shares of telemedicine kingpin <b>Teladoc Health</b> (NYSE:TDOC) would be a perfect use of $1,000 for the fourth quarter.</p>\n<p>When the pandemic hit, there's no sugarcoating that Teladoc was in the right place at the right time. With doctors wanting to keep potentially sick and high-risk people out of their offices, they regularly turned to virtual visit platforms, such as those offered by Teladoc. Last year, Teladoc handled almost 10.6 million visits, which was well over double the 4.14 million visits in 2019.</p>\n<p>Some skeptics have cautioned that Teladoc could be a one-hit wonder considering the worst of the pandemic may now be in the rearview mirror. However, this view overlooks the many lasting changes telemedicine brings to the table. It's far more convenient for patients, can allow doctors to keep better tabs on their chronic-care patients, and should result in better patient outcomes and lower total treatment costs for insurers. There's a reason Teladoc's annual sales growth averaged 74% in the six years leading up to the pandemic.</p>\n<p>Teladoc Health also acquired the nation's leading applied health signals company, Livongo Health, in the fourth quarter of 2020. Livongo leans on artificial intelligence to send tips to its chronic-care members to help them lead healthier lives. While most of Livongo' 715,000 chronic-care enrollees are diabetics, it aims to offer its services to those with weight management issues and hypertension, as well. In other words, we're watching the very early innings of a personalized care disruptor.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 5 Perfect Stocks to Buy for the Fourth Quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-28 21:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/09/28/got-1000-5-perfect-stocks-buy-for-fourth-quarter/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>If investors thought the coronavirus crash was historic, the bounce-back rally from the March 2020 bottom has been even more impressive. The benchmark S&P 500 took less than 17 months to double from ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/09/28/got-1000-5-perfect-stocks-buy-for-fourth-quarter/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","EXEL":"伊克力西斯","VRTX":"福泰制药","AVGO":"博通","TDOC":"Teladoc Health Inc."},"source_url":"https://www.fool.com/investing/2021/09/28/got-1000-5-perfect-stocks-buy-for-fourth-quarter/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2170672462","content_text":"If investors thought the coronavirus crash was historic, the bounce-back rally from the March 2020 bottom has been even more impressive. The benchmark S&P 500 took less than 17 months to double from its lows, and it's now gone 10 months without so much as a 5% downside correction. Patience is truly paying off for long-term investors.\nBut just because the broader market is a stone's throw from a record high doesn't mean investors can't still find bargains. If you've got $1,000 ready to invest, which won't be needed for bill or emergencies, the following five stocks would make for perfect buys for the fourth quarter.\nImage source: Getty Images.\nNovavax\nWhile I'm generally not a fan of chasing the coronavirus stocks after they've catapulted into the stratosphere, clinical-stage biotech stock Novavax (NASDAQ:NVAX) is the rare exception. It's unlikely to remain a clinical-stage company for much longer and could offer clear advantages that'll help it become a top vaccine player.\nThe company's coronavirus disease 2019 (COVID-19) vaccine, NVX-CoV2373, led to an 89.7% vaccine efficacy (VE) in a large-scale trial in the U.K. earlier this year, and it produced a nearly identical 90.4% VE in a large-scale trial in the U.S. and Mexico in June. This initial efficacy, coupled with the less-than-stellar uptake from AstraZeneca's and Johnson & Johnson's COVID-19 vaccines, should open the door for Novavax to become the No. 3 player in developed markets.\nAlso working in Novavax's favor is the mutability of the SARS-CoV-2 virus that causes COVID-19. Novavax's drug-development platform is capable of quickly bringing variant-specific vaccines to trial, if necessary. The company could also benefit from the need for booster shots, depending on how long vaccine-based immunity lasts.\nNovavax has an opportunity to beat its peers to market with a combination COVID-19/influenza vaccine, as well. This could be a differentiating vaccine that really allows the company to stand out.\nImage source: Getty Images.\nExelixis\nBiotech stocks are a common theme on this list of perfect stocks to buy for the fourth quarter. Cancer drug developer Exelixis (NASDAQ:EXEL) offers the right blend of growth and value to make patient investors richer.\nThe superstar for Exelixis continues to be cancer drug Cabometyx, which derives the bulk of its sales from its first-and-second-line approvals in renal cell carcinoma (RCC) and its approval to treat advanced hepatocellular carcinoma. These indications should help Cabometyx top $1 billion in recurring sales either this year or 2022.\nThe only reason this company is as inexpensive as it is now -- 21 times forward-year earnings for sustainable mid-teens sales growth -- is the disappointing update from the Cosmic-312 trial. Though the combination of Cabometyx and atezolizumab led to a statistically significant improvement in progression-free survival for previously untreated liver cancer patients, Exelixis notes that it's unlikely to demonstrate a statistically significant improvement in overall survival by trial completion in early 2022.\nWhile this might sound like a disappointment, it isn't. It's par for the course when developing blockbuster cancer drugs. Cabometyx failed in a late-stage study targeted at prostate cancer patients in 2014 but has since bounced back to gain numerous approvals. With this key drug being examined in close to six dozen clinical trials, label expansion opportunities remain abundant for Exelixis.\nImage source: Getty Images.\nBroadcom\nStepping outside the healthcare arena for the moment, semiconductor solutions provider Broadcom (NASDAQ:AVGO) is a perfect stock to put $1,000 to work in for the fourth quarter. I say \"perfect,\" because Broadcom is at the center of two very sustainable growth trends.\nFirst, it's going to be a multiyear beneficiary of the rollout of 5G wireless infrastructure. A majority of Broadcom's revenue comes from wireless chips and other accessories found in smartphones. Because it's been a decade since consumers and businesses have benefited from an upgrade to wireless download speeds, the expectation is that we'll see a sustainable, multiyear device replacement cycle. This should allow Broadcom to lock in its orders months or years in advance.\nBut it's not just smartphones that should have investors excited about Broadcom. The pandemic has also accelerated the shift of enterprise and consumer data into the cloud. This means data center demand should be strong for a long time to come. Broadcom is a provider of connectivity and access chips used by enterprise data centers.\nThe icing on the cake here is that the company has grown its quarterly dividend by more than 5,000% in less than 11 years. Investors can collect a nearly 3% yield as they sit back and watch Broadcom's profitability climb.\nImage source: Getty Images.\nVertex Pharmaceuticals\nSimilar to Exelixis, specialty biotech stock Vertex Pharmaceuticals (NASDAQ:VRTX) offers the right blend of double-digit sales growth and insane value (a forward-year price-to-earnings ratio of only 14), which makes it a no-brainer buy for the fourth quarter.\nWhat allows Vertex to stand out is its overwhelming success in developing multiple generations of treatments for patients with cystic fibrosis (CF). CF is a genetic disease characterized by thick mucus production that can obstruct the pancreas and/or lungs. Vertex's latest treatment, combination therapy Trikafta, was approved five months ahead of the U.S. Food and Drug Administration's review date, and is pacing $5 billion in annual run-rate sales despite hitting pharmacy shelves less than two years ago.\nKeeping with the similarities to Exelixis, Vertex was hit hard twice over the past year after two separate experimental treatments targeting alpha-1 antitrypsin deficiency were discontinued in mid-stage trials. Nevertheless, Vertex has more than a half-dozen combined internal and out-licensed treatments in development for a variety of indications. Even though its CF franchise is well-protected from competition, the company is working on an expansive pipeline of products.\nAnd don't overlook Vertex's cash pile. It ended June with about $6.7 billion in cash and cash equivalents, which is more than enough to fuel internal development, fund novel partnerships, or make acquisitions.\nImage source: Getty Images.\nTeladoc Health\nLastly, buying shares of telemedicine kingpin Teladoc Health (NYSE:TDOC) would be a perfect use of $1,000 for the fourth quarter.\nWhen the pandemic hit, there's no sugarcoating that Teladoc was in the right place at the right time. With doctors wanting to keep potentially sick and high-risk people out of their offices, they regularly turned to virtual visit platforms, such as those offered by Teladoc. Last year, Teladoc handled almost 10.6 million visits, which was well over double the 4.14 million visits in 2019.\nSome skeptics have cautioned that Teladoc could be a one-hit wonder considering the worst of the pandemic may now be in the rearview mirror. However, this view overlooks the many lasting changes telemedicine brings to the table. It's far more convenient for patients, can allow doctors to keep better tabs on their chronic-care patients, and should result in better patient outcomes and lower total treatment costs for insurers. There's a reason Teladoc's annual sales growth averaged 74% in the six years leading up to the pandemic.\nTeladoc Health also acquired the nation's leading applied health signals company, Livongo Health, in the fourth quarter of 2020. Livongo leans on artificial intelligence to send tips to its chronic-care members to help them lead healthier lives. While most of Livongo' 715,000 chronic-care enrollees are diabetics, it aims to offer its services to those with weight management issues and hypertension, as well. In other words, we're watching the very early innings of a personalized care disruptor.","news_type":1},"isVote":1,"tweetType":1,"viewCount":667,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":867178738,"gmtCreate":1633231618615,"gmtModify":1633231618736,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"💰💰💰","listText":"💰💰💰","text":"💰💰💰","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/867178738","repostId":"1134305481","repostType":4,"repost":{"id":"1134305481","pubTimestamp":1633152909,"share":"https://www.laohu8.com/m/news/1134305481?lang=&edition=full","pubTime":"2021-10-02 13:35","market":"hk","language":"en","title":"3 Stocks That Can Double Again in the Fourth Quarter","url":"https://stock-news.laohu8.com/highlight/detail?id=1134305481","media":"The motley fool","summary":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this mo","content":"<p>Key Points</p>\n<ul>\n <li>Crocs has jacked up its guidance every quarter this year. It reports again later this month.</li>\n <li>AMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.</li>\n <li>Upstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.</li>\n</ul>\n<p></p>\n<p>It's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?</p>\n<p><b>Crocs</b>&nbsp;(NASDAQ:CROX),<b>AMC Entertainment</b>(NYSE:AMC), and<b>Upstart</b>&nbsp;(NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.</p>\n<p>1. Crocs</p>\n<p>Remember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.</p>\n<p>The comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.</p>\n<p>The year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?</p>\n<p>Despite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.</p>\n<p>2. AMC Entertainment</p>\n<p>You may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.</p>\n<p>However, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?</p>\n<p>Fundamentally speaking, the catalysts are also there.<i>Shang-Chi and the Legend of the Ten Rings</i>shattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.</p>\n<p>3. Upstart</p>\n<p>I love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.</p>\n<p>Growth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.</p>\n<p>With Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks That Can Double Again in the Fourth Quarter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks That Can Double Again in the Fourth Quarter\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-02 13:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/><strong>The motley fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UPST":"Upstart Holdings, Inc.","AMC":"AMC院线","CROX":"卡骆驰"},"source_url":"https://www.fool.com/investing/2021/10/01/3-stocks-that-can-double-again-in-the-fourth-quart/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1134305481","content_text":"Key Points\n\nCrocs has jacked up its guidance every quarter this year. It reports again later this month.\nAMC would have to double from here to revisit its June highs. Check the upcoming theatrical release slate to know why movie theaters are about to get a whole lot better.\nUpstart is revolutionizing the way creditworthiness is determined in consumer loans, and it's laughing all the way to the bank.\n\n\nIt's been a volatile year for stocks, but naturally some investments have fared better than others. Over 300 stocks have more than doubled in 2021. Many of those winning investments will be lucky if they can hold those gains through the final three months of the year, but what about the names that have the potential to double again?\nCrocs (NASDAQ:CROX),AMC Entertainment(NYSE:AMC), andUpstart (NASDAQ:UPST)have more than doubled in value through the first nine months of 2021. Let's see why they have what it takes to possibly repeat the feat in the fourth quarter.\n1. Crocs\nRemember those bright rubbery shoes with holes in them? They're back in a big way. Crocs sales are booming since the pandemic began, and the stock is following suit with a 129% increase through the first nine months of 2021.\nThe comfortable resin shoes were already making a comeback before the COVID-19 crisis with double-digit revenue growth in 2019 before repeating the feat in 2020. Momentum is what's really taking Crocs to a higher level in 2021.\nThe year began with the footwear maker projecting 20%-to-25% top-line growth for the entire year back in February. Guidance was bumped higher -- to between 40% and 50% growth -- the following quarter. It happened again this summer, with Crocs now targeting a 60%-to-65% surge in revenue for all of 2021. What do you think will happen if those targets get pushed even higher when it reports third-quarter results later this month?\nDespite a stock that has popped nearly sixfold since the start of 2019, Crocs is reasonably priced given its accelerating growth. It's trading at 21 times this year's earnings and just 17 times next year's target. There's clearly room to increase those multiples, and Wall Street's finally as comfortable with Crocs as an investment as its customers are in its shoes.\n2. AMC Entertainment\nYou may be surprised to find the country's leading multiplex operator on this list, but plot twists are what make movies so good. It's certainly true that AMC Entertainment has appreciated -- in terms of both stock price and a fivefold explosion in shares outstanding -- to the point where its valuation is out of whack relative to its peers'. If you want a pure investing play on the movie theater industry's recovery, you will find more attractively priced stocks toscratchthatitch.\nHowever, as ameme stockand cultural phenomenon it's hard to argue against what AMC has done to translate its popularity among retail investors into a legitimate market share grab in the recovery process. No company has seen its market cap inflate as much as AMC has this year, but this is also a stock that enters the fourth quarter with a stock price that is a little more than half of what it was when it peaked in June. In short, it would have to double from here to revisit its all-time high -- but isn't that always possible with the poster child for 2021 momentum stocks?\nFundamentally speaking, the catalysts are also there.Shang-Chi and the Legend of the Ten Ringsshattered box office records over Labor Day weekend, but the initial excitement fizzled out when subsequent weekends were abysmal. However, it's all about the pipeline. Studios pushed out September releases into October and beyond when the delta variant resulted in a spike in COVID-19 cases. We're now seeing the highly anticipated films start to come back, starting with the new James Bond movie next weekend. The fourth quarter should be a lot stronger for the industry than the naysayers think, and if AMC stock gets back to where it was in early June -- fundamentally earned this time -- it will have to double from here.\n3. Upstart\nI love when industries ripe for disruption get upended, and that's what Upstart is doing with the lending industry. Upstart usesartificial intelligenceand machine learning to make better calls on assessing risk profiles and creditworthiness for folks who don't typically get approved for consumer loans.\nGrowth is bonkers. Revenue seemed to be decelerating sharply, with slowing growth spurts of 89%, 52%, and 27% in the last three years respectively. Now that consumers are becoming aware of Upstart as a better alternative to payday loans and other predatory lending products, business is skyrocketing. Revenue rose 90% in the first quarter, only to surge 1,018% in its latest report. And no, that's not a typo.\nWith Upstart now expanding into the auto loans market, the potential for its better alternative to stodgy credit scores is just getting started. The stock has been a seven-bagger through the first three quarters of 2021, but the runway is long for this disruptive jet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":374,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":860343767,"gmtCreate":1632141082659,"gmtModify":1632802592476,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Appreciate the insight 🙏🏻Thank you&nbsp;","listText":"Appreciate the insight 🙏🏻Thank you&nbsp;","text":"Appreciate the insight 🙏🏻Thank you","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/860343767","repostId":"1130418583","repostType":4,"isVote":1,"tweetType":1,"viewCount":109,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887064786,"gmtCreate":1631946225845,"gmtModify":1632805137073,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"Awesome!&nbsp;","listText":"Awesome!&nbsp;","text":"Awesome!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887064786","repostId":"1171574345","repostType":4,"repost":{"id":"1171574345","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1631887879,"share":"https://www.laohu8.com/m/news/1171574345?lang=&edition=full","pubTime":"2021-09-17 22:11","market":"us","language":"en","title":"Big Tech shares slid in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1171574345","media":"Tiger Newspress","summary":"Big Tech shares slid in morning trading.Apple,Microsoft,Alphabet and Facebook fell about 1%.","content":"<p>Big Tech shares slid in morning trading.Apple,Microsoft,Alphabet&nbsp;and&nbsp;Facebook&nbsp;fell about&nbsp;1%.</p>\n<p><img src=\"https://static.tigerbbs.com/e49451789aace23ecef6daa125c80847\" tg-width=\"409\" tg-height=\"358\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Big Tech shares slid in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBig Tech shares slid in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-09-17 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Big Tech shares slid in morning trading.Apple,Microsoft,Alphabet&nbsp;and&nbsp;Facebook&nbsp;fell about&nbsp;1%.</p>\n<p><img src=\"https://static.tigerbbs.com/e49451789aace23ecef6daa125c80847\" tg-width=\"409\" tg-height=\"358\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GOOGL":"谷歌A","NFLX":"奈飞","AMZN":"亚马逊","AAPL":"苹果","MSFT":"微软","GOOG":"谷歌"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171574345","content_text":"Big Tech shares slid in morning trading.Apple,Microsoft,Alphabet and Facebook fell about 1%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":258,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887593855,"gmtCreate":1632059211377,"gmtModify":1632803090001,"author":{"id":"4090310005874460","authorId":"4090310005874460","name":"韓靚嫻","avatar":"https://static.tigerbbs.com/3a8e47ca97a84fc05f9f5baaf080ba02","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"4090310005874460","idStr":"4090310005874460"},"themes":[],"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887593855","repostId":"1187895428","repostType":4,"isVote":1,"tweetType":1,"viewCount":131,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}